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ALL-PHOTONIC CONTROL OF BIORELEVANT PROCESSES USING 
MOLECULAR PHOTOSWITCHES AND CAGED COMPOUNDS 
JESPER R. NILSSON 
Department of Chemistry and Chemical Engineering 
Chalmers University of Technology 
Abstract 
The development of light-controlled molecular tools for in situ regulation of biological 
activity holds great promise e.g. for resolving dynamic aspects of cellular signal 
transduction and to overcome inherent pharmaceutic limitations such as poor drug 
selectivity. In this thesis, photoswitchable molecules from the spiropyran, 
dithienylethene, and azobenzene families as well as an o-nitrobenzyl-type caged 
compound were used in a variety of constellations intended for biological use. The 
presented research ranges from spectroscopic studies on isolated molecular 
interactions in solution to photoactivated kinase inhibition in live zebrafish. 
The first part of this thesis focuses on novel approaches for photocontrolled drug 
release, based on a supramolecular competitive binding methodology. Two host-guest 
systems were investigated for this purpose; a dithienylehtene – porphyrin dimer, and a 
spiropyran – cucurbit[7]uril (CB7) system. In the first investigated system, it was found 
that drug release could be reversibly controlled by light. The spectral properties of the 
release scaffold also provided a fluorescence-based reporting function. In the second 
system, an unexpected loss of spiropyran bistability was observed upon complexation 
to CB7. Also, the undesired hydrolysis of the spiropyran photoswitch was completely 
halted when bound to the macrocycle. The spiropyran hydrolysis reaction was further 
examined in a separate study, also included in this thesis. 
The second and thirds parts focus on photocontrolled small-molecules introduced 
to living systems. This includes a study on the cytotoxic properties of a DNA-binding 
spiropyran in live human cancer cells. It was demonstrated how cell-death could be 
selectively triggered by photoisomerizing the spiropyran to the merocyanine form 
inside the cells. Part three focuses on photocontrolled inhibition of the, for cancer 
highly relevant, REarranged during Transfection (RET) kinase. An azobenzene-
derived photoswitch and an o-benzyl-type caged inhibitor based on the 
pyrazolopyrimidine scaffold were developed and evaluated. Both compounds 
exhibited light-controlled RET inhibition in an isolated enzyme- and live cell assay. 
The caged compound was also used to photonically activate inhibition of RET in live 
zebrafish, confirming uptake and decaging of the compound inside the live organism. 
 
Keywords: photoswitch, caged compound, drug release, spiropyran, dithienylethene, 
azobenzene, o-nitrobenzyl, kinase inhibitor, live cell, spectroscopy. 
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1 Thesis Introduction 
  
2 
Potent and selective therapeutic compounds are essential tools in clinical medicine. By 
studying the structure and native function of biochemical targets, biomedical 
researchers strive to design molecules that are able to interact with and perturb target 
activity, to yield therapeutic benefits for the patient. Iterative testing-redesign programs 
are applied to identify the most suitable drug candidate with respect to efficacy and 
safety, which is then taken through the different phases of clinical trials. This well-
established scheme is at the heart of modern rational drug design and has helped build 
the impressive catalogue of drugs we have on the market today. However, there exists 
a serious limitation inherent to traditional pharmacotherapy; after distributing the 
compound, there is no way to regulate when and where the molecule is active – all 
control over that agent is essentially lost. This intrinsic lack of control combined with 
imperfect target selectivity in the designed drugs, frequently lead to more or less severe 
adverse drug reactions and patient suffering.1 This is particularly recognizable for 
aggressive therapeutic treatments such as chemotherapy. 
The chemical biologist is held back by the same limitation. Signal transduction 
research relies heavily on the development of strongly interacting and selective small-
molecule effectors.2,3 By studying the cellular response(s) following modulation of 
biochemical pathways involved in pathophysiological processes, information on how 
these signaling cascades are interconnected can be extracted. This type of refined 
knowledge is crucial when trying to understand overall cause-and-effect relationships 
of drug-target interactions and how to efficiently regulate them. However, since these 
signaling events are time- and space-dependent processes, valuable information is lost 
if we cannot control when and where the molecular probe is active.4  
The above paragraphs are examples meant to highlight the usefulness of 
developing externally controllable molecular tools. They serve to introduce this thesis, 
which main objective is to describe how light can be used to control molecular structure 
and how this concept can be applied to create biologically relevant tools and 
applications. Light is a versatile stimulus able to instantly interact with molecules 
without having to add additional chemicals. Also, under certain conditions, light to 
which biological tissue is more or less transparent can be applied to remotely trigger 
molecular events inside our body.5 The development of photocontrolled biological 
tools is primarily motivated by the increased selectivity that comes with the spatiotemporal 
resolution of light. It should be noted that the photocontrolled applications presented 
in this thesis (in their current state) are far from being useful in any clinical application. 
Nevertheless, the prospective use of a general photocontrolled system is exemplified 
from a clinical viewpoint in Figure 1. 
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Figure 1. Comparison between traditional pharmacotherapy and a photocontrolled approach. 
Left panel: In the traditional approach, the administered drug (red color) is typically also the 
target-interacting drug.‡ Due to more or less inadequate selectivity, regions other than the target 
area are also exposed to the drug, leading to treatment-related side effects. Right panel: In the 
photocontrolled approach, the light-responsive drug can be designed to be inactive in the 
administered form (green color). Upon exposing the target area to light (iii), the drug can be 
selectively activated (red color) in a highly localized manner.  
Two main strategies for inferring light-responsiveness in molecular samples are 
described in this thesis; using photochromic4,6-11 and photocaged4,10-16 compounds. 
Photocromic compounds, (photoswitches) are a class of molecules that can be 
reversibly transformed between two or more forms using light. As the name 
photochrome [chroma (χρώμα), greek = color] implies, the molecular transformation is 
typically accompanied by a change in color of the compound. You may already be 
familiar with some photochromic devices. The arguably most recognized example is 
photochromic eyewear, which darken in response to UV light from the sun. What is 
perhaps less obvious is that the change in color is due to a structural rearrangement in 
the molecules embedded in the plastic laminate on the glasses. In this case, the color 
change itself serves a purpose but in fact, virtually all physicochemical characteristics 
of the photoswitch change to some extent upon light exposure; the size, shape, 
structural flexibility, polarity, redox properties, etc. One may say that light has created 
an entirely new molecule. In this thesis, the focus is not so much on the color change 
but rather on how to harness the other properties that come with it, to afford for 
instance photoswitchable binding affinity and biological activity. As mentioned above, 
a photocaged strategy has also been explored. Caged compounds are photoresponsive 
molecules that, in contrast to the reversible nature of photoswitches, are irreversibly 
transformed by light. 
                                                          
‡ One exception is the use of so-called prodrugs, which are activated in the metabolic process in the 
body. 
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This general introduction is followed by two chapters, in which some underlying 
theoretical considerations related to light-matter interactions are introduced 
(chapter 2), along with a brief account on the main experimental techniques (chapter 3) 
used in the appended research. This should hopefully provide an adequate theoretical 
foundation for the comprehension of the presented results. Readers well-accustomed 
to the language of physical chemistry may perceive parts of these chapters as more-
than-comprehensible, and should approach them as they see fit. 
Further on, in chapter 4, an overview of the existing strategies for controlling 
biological systems with light are outlined. This includes a description of the working 
principle of photoswitches and photocages, along with a brief account on strategies for 
extending the usability of photoresponsive compounds through supramolecular 
arrangements with non-photochromic molecules. Protein kinases fulfills an important 
role as a biological target in this thesis. Therefore, a description of their overall function 
is also included. 
The original research presented in this thesis is based on the six appended papers 
(from here on referred to as Papers I-VI). The results are summarized in chapter 5, 
which is organized into three parts. The first part (section 5.1) focuses on fundamental 
intermolecular interactions between photoswitches and non-photochromic molecules. 
It includes two projects exploring a drug displacement methodology to achieve 
photoswitchable drug release systems. These systems rely on supramolecular 
interactions between a spiropyran photoswitch and the cucurbit[7]uril macrocycle 
(Paper II), as well as a dithienylethene photoswitch and a porphyrin dimer (Paper IV). 
Also presented in the first part is a kinetic characterization study of a series of 
photoswitches from the spiropyran family in buffer solution (Paper III). In particular, 
the unwanted hydrolytic reaction of spiropyrans is scrutinized on.  
The results in the second and third parts of chapter 5 (sections 5.2 and 5.3, 
respectively) lie closer to the field of molecular biology, as they both include studies on 
living systems. In part two, the light-induced cytotoxic- and uptake properties of a 
spiropyran were studied in a human cancer cell-line (Paper I). Part three focuses 
exclusively on photocontrolled enzyme inhibition. There, an azobenzene-derived 
photoswitch (Paper V) and o-nitrobenzyl-type caged compound (Paper VI) for gaining 
photonic control over the inhibition of a receptor tyrosine kinase are described. 
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2 Fundamentals 
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There is no simple way of explaining how light interacts with matter and any attempt 
to thoroughly do so is well beyond the scope of this thesis. Nevertheless, as most of 
the concepts discussed herein involves light-matter interactions, a brief account on 
selected qualities is presented below. The latter part of this chapter is dedicated to 
host-guest chemistry, since a significant part of my work revolves around these 
concepts. This includes the supramolecular strategies described in Papers II and IV, as 
well as kinase inhibition in Papers V and VI. 
2.1 Light 
Light is successfully described as two things at once. One often refers to the wave-particle 
duality of light, where it on one hand is described as an oscillating electromagnetic wave 
propagating through space, and on the other hand as a flow of discrete, (rest-) massless 
energy particles. The wave description depicts light as consisting of two periodically 
oscillating components, one electric and one magnetic, on a right angle to each other 
and the direction of propagation (Figure 2). Light was shown to possess a wave-like 
character as early as the 1600’s through the work of Hooke, Huygens and Euler. It was 
not until the 1860’s, however, that Scottish physicist James Clerk Maxwell was able to 
propose a comprehensive set of differential equations, effectively assigning co-varying 
electric and magnetic properties to light.17 
 
 
 
Figure 2. The electromagnetic wave-description of light. 
The familiar graphic representation shown in Figure 2 is a consequence of the Maxwell 
equations, which (although derived solely from classical physics) remain extraordinarily 
accurate in predicting experimental outcomes where light can be regarded purely as a 
wave. In the year 1900, inspired by his studies on black body radiation, Max Planck 
postulated that all systems that emit light do so in discrete units of energy – quanta.18 
The proportionality constant is called Planck’s constant (݄), and it follows that the 
energy (ܧ) of quanta can be calculated according to equation [1]. 
 ܧ ൌ ݄ߥ [1] 
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Here ߥ  is the frequency of oscillation. For light with wavelength ߣ  travelling at a 
constant speed (ܿ), the energy can be calculated according to equation [2].  
 ܧ ൌ ݄ܿߣ  
[2] 
The concept of discrete energy packets (photons, as they were later termed)19, did not 
resonate with the established wave-description of light. Nevertheless, Heinrich 
Hertz’s20 and Einstein’s21 contemporary experiments on the photoelectric effect 
strongly supported Planck’s ideas on quantized energy. An important contribution in 
reference to the wave-particle discussion was put forward in 1924 by French physicist 
Louis de Broglie,22 in which he proposed that all particles (at the time he was referring 
to the electron) in fact moves like waves – matter-waves. The de Broglie hypothesis 
further muddled the distinction between energy, particles, and waves, highlighting the 
need for a unified theory of light and matter. Today, following the paradigm shift of 
the quantum revolution and years of subsequent refinements, we have arrived at a 
quantum mechanical description of light in which the abovementioned aspects can be 
accounted for. The notion of wave-particle duality still holds, however, and the two 
representations are used interchangeably. 
2.2 Matter 
In the Bohr atom model, which emerged in 1913, the atom was proposed to consist of 
a positively charged nucleus around which electrons orbit at set distances – shells, 
representing energy levels.23 Moving an electron between these shells proceeds in 
concert with absorption or emission of light. With this model, Bohr was able to justify 
the mathematical equations explaining atomic spectral line patterns observed for 
instance in electric discharge experiments (e.g. the Rydberg formula), and show that the 
proportionality did in fact adhere to the abovementioned Planck relation. The 
requirement for light to exactly match the energy difference between an initial state (݅) 
and a final state (݂) in an atom or molecule is therefore called the Bohr frequency condition 
and can be expressed according to equation [3]. 
 ܧ௙ െ ܧ௜ ൌ ݄ߥ [3] 
Based on the Bohr model and the de Broglie matter-wave hypothesis, wave mechanics 
(largely based on the work of Erwin Schrödinger),24 emerged as a quantum mechanical 
adaptation for describing the quantum nature of matter. The wave-description of 
matter, in combination with Heisenberg’s uncertainty principle,25 changed the 
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perception of electron motion in atoms. Instead of orbiting the nucleus (as in the Bohr 
model), the electrons were depicted as residing within nuclei-centered probability 
distributions – orbitals. The atomic orbitals are obtained by solving the Schrödinger 
equation for the atom in question. What determines the properties of an atom is the 
number of protons and neutrons in the nucleus and how the atomic orbitals are 
populated by electrons i.e. the electron configuration.  
Molecular orbitals, depicting the electron density across an entire molecule, can in 
turn be approximated by linear combinations of the involved atomic orbitals. The 
ground state electron configuration of atoms and molecules are worked out by pairing 
electrons in the orbitals according to the Aufbau principle, Pauli exclusion principle and 
Hund’s rule. The relative energies and electron occupancy of molecular orbitals can 
provide insights into photophysical processes. Of particular importance are the highest 
occupied- and the lowest unoccupied molecular orbitals (HOMO and LUMO, 
respectively) which are central in the so called Frontier Molecular Orbital theory.26 
Depending on the number of electrons and relative energies of the available orbitals, 
unpaired electrons may occur, resulting in different spin multiplicities. The by far most 
frequent scenario in the ground state is to have a spin multiplicity of 1. This occurs 
when the molecule contain spin-paired electrons, and the state is called a singlet. For 
molecules with two unpaired electrons, the spin multiplicity is 3 and the corresponding 
state is called a triplet. Triplets are very uncommon in the ground state of a molecule 
but exceptions exists, for instance molecular oxygen. 
Each electronic state in a molecule contain several vibrational states and each 
vibrational state several rotational states, all of which are quantized. This implies that 
there are large differences in the energy required to stimulate these transitions. By 
applying the Boltzmann distribution to calculate the relative occupancy of these states in 
the absence of light at room temperature, it can be concluded that a typical 
small-molecule in solution populates the lowest vibrational state of the lowest 
electronic state. 
2.3 Photoexcitation 
The mathematical framework of quantum mechanics provides a concise (albeit 
abstract) means of describing not only the state of a molecule, but also the mechanisms 
with which it transfers from one state to another. The probability for a molecule to 
absorb light can be said to depend on how well the incident light resonates with the 
change in the electronic landscape of the molecule. In quantum mechanics, perturbation 
theory27 can be used for approximating the responses of molecules to weak disturbances. 
Fermi’s golden rule, as stated in equation [4], gives the probability ( ௙ܲ௜) per unit time of a 
perturbation-induced transition from an initial state (ߖ௜) to final state (ߖ௙). 
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 ݀ ௙ܲ௜
݀ݐ ൌ ʹߨߩหൻߖ௙หܪ෡Ԣหߖ௜ൿห
ଶ
 [4] 
The integration implied in the bra-ket notation is taken over all space, and ߩ is the 
density of final states. When the perturbation is induced by light, the perturbing 
Hamiltonian (ܪ෡Ԣ) can be approximated by the scalar product between the electric field§ 
of light, ܧതሺݐሻ, and the dipole operator (ߤƸ ), as shown in equation [5]. 
 ݀ ௙ܲ௜
݀ݐ ൌ ʹߨߩหൻߖ௙หܧതሺݐሻ ή ߤƸ หߖ௜ൿห
ଶ
 [5] 
Here, ߤƸ  evaluates the charge-weighted distances of all species in the molecule 
according to equation [6]. 
 ߤƸ ൌ ෍ݍ௝ݎҧ௝
௝
 [6] 
Assuming the electric field is uniform over the molecule, **  the time-dependent 
probability can be written according to equation [7]. 
 ݀ ௙ܲ௜
݀ݐ ൌ
ʹߨሺܧത଴ ή ߤҧ௙௜ሻଶ
݄ଶ ߩఔሺߥ௙௜ሻ 
[7] 
Here, ܧത଴ is the amplitude and ߩఔሺߥ௙௜ሻ the number of oscillation modes of the electric 
field at the transition frequencyߥ௙௜. The transition dipole moment (ߤҧ௙௜) is also introduced 
in equation [7]. This molecule- and transition-specific parameter can be interpreted as 
a vector pointing in the direction of the net electron flow as the molecule is excited. It 
is defined in terms of the dipole operator according to equation [8]. 
 ߤҧ௙௜ ൌ ൻߖ௙หߤƸ หߖ௜ൿ [8] 
From the above exercise (see in particular equation [7]), two factors can be identified 
as determining the intensity of light absorption. First, the transition dipole moment 
squared (ߤҧ௙௜ଶ), also referred to as the dipole strength and second, the scalar product      
                                                          
§  Due to the relative difference in strength (electric interactions are significantly stronger than 
magnetic) it is often considered sufficient to include only interactions between the electric field component 
of light and the electric charges of the molecule, while a full treatment would also require the magnetic field 
component to be taken into account. 
** The wavelength of the oscillating light used in molecular spectroscopy is significantly longer (for 
example ca. 200-800 nm in UV/vis spectroscopy) than the corresponding molecular spatial dimension (ca. 
1-10 nm), justifying the assumption of uniformity. 
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ܧത଴ ή ߤҧ௙௜, which infers a cosine squared directionality condition between the incident 
electric field vector and the transition dipole moment vector. The theoretically deduced 
dipole strength is directly proportional to the molar absorption coefficient,ߝሺߥሻ. Molecules 
with appreciably large molar absorption coefficients in the visible electromagnetic 
region are called chromophores. This parameter and its relation to molar absorption are 
discussed further in section 3.1. 
2.4 Excited State Processes 
The excited state processes described in this section are those of a typical chromophore 
in solution. It is by no means an exhaustive description of all possible excited state 
processes. Note in particular that intermolecular excited state reactions are not 
considered. Upon photon absorption, a molecule (ܯ) is promoted from the ground 
state (ܵ଴) to an electronically excited state (ܵ௡). This can be denoted as shown in 
reaction [9]. 
 ܯ ൅ ݄ߥଵ ՜ ܯכ [9] 
In molecules, the destination state is typically a vibrationally excited state within the ܵ௡ 
electronic state, making the absorption event a vibronic transition. The available 
processes through which a molecule dissipate absorbed energy, can be summarized in 
a Jablonski dagram (Figure 3). 
 
Figure 3. Jablonski diagram illustrating absorption and excited state deactivation processes. 
Electronic states are shown as bold horizontal lines, these include singlet states (ܵ଴, ଵܵ,ܵ௡) and 
a triplet state ( ଵܶ). Vibrational states are shown as gray horizontal lines. All radiative processes 
are represented by straight arrows. These are absorption (blue), fluorescence (green), and 
phosphorescence (red). The non-radiative processes are depicted as wavy arrows and include 
vibrational relaxation (VR), internal conversion (IC), and intersystem crossing (ISC). 
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Following excitation toܵ௡, the molecule typically relaxes to the lowest vibrational state 
of ଵܵ through a combination of very efficient non-radiative processes. The relaxation 
processes leading to the ଵܵ  state occur on a much shorter time scale than the 
corresponding processes depopulating ଵܵ  (due to the Energy gap law). Excited state 
processes are therefore approximated as proceeding exclusively from ଵܵ. This is often 
referred to as Kasha’s rule.28 Once in ଵܵ, the molecule can relax to the ground state via 
one of the following three routes. (1) Non-radiative relaxation. This involves internal 
conversion (IC), a horizontal (isoenergetic) transition between electronic states of the 
same multiplicity, followed by dissipation of energy to solvent molecules through 
vibrational relaxation (VR). (2) Through the triplet state. For this to occur the molecule 
has to first undergo a spin-forbidden horizontal transition (inter system crossing, ISC) to 
the triplet state, ଵܶ. From  ଵܶ the molecule can return to  ଵܵ either by emitting a photon 
or by relaxing non-radiatively. Emissive relaxation from a triplet state to a singlet state 
is called phosphorescence. (3) Radiative relaxation. The spin-conserved emission of a 
photon is called fluorescence and, analogous to the word chromophore (for visible light 
absorbers), fluorescent molecules are called fluorophores. Emissive decay, either via 
fluorescence of phosphorescence, can be written according to reaction [10]. 
 ܯכ ՜ ܯ ൅ ݄ߥଶ [10] 
To express the fraction of molecules relaxing via a specific pathway a quantum yield (ߔ) 
is defined. The quantum yield for a specific process is simply the number of 
process-specific events per absorbed photon. It follows that the rate (݇௜) with which 
process ݅ proceeds can be used to define the quantum yield, as shown in equation [11]. 
 ߔ௜ ൌ
͓݁ݒ݁݊ݐݏ݋݂ݐݕ݌݁݅
͓݌݄݋ݐ݋݊ݏܾܽݏ݋ݎܾ݁݀ ൌ
݇௜
σ ௝݇௝  
[11] 
Here, the sum σ ௝݇௝  denotes the rates (including݇௜ ) with which ଵܵ is depopulated. 
Another important property of a molecule is how for long it stays in the excited state. 
The excited state lifetime (߬௙) of a molecule is defined according to equation [12] and 
describes the average time the molecule spends in the excited state. 
 ߬௙ ൌ
ͳ
σ ௝݇௝  
[12] 
Two quantum yields are particularly relevant in this thesis; the fluorescence- and 
isomerization quantum yields, ߔ௙  andߔ௜௦௢ , respectively. The latter is discussed in 
section 2.4.2.   
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2.4.1 Excitation Energy Transfer (EET) 
Under certain conditions, the excited state of a molecule can be depopulated by 
transferring its excitation quanta to an adjacent molecule. Following the convention of 
reactions [9] and [10], this can be expressed according to the following series of 
reactions, involving the donor (ܦ) and acceptor (ܣ) of the quanta. 
 ܦ ൅ ܣ ൅ ݄ߥଵ
ͳ
՜ܦכ ൅ ܣ
ʹ
՜ܦ ൅ ܣכ
͵
՜ܦ ൅ ܣ ൅ ݄ߥଷ  [13] 
The energy transfer step (reaction [13], step 2) can occur either via electron exchange 
(Dexter energy transfer) or Förster resonance energy transfer, FRET.29 While the Dexter 
mechanism requires orbital overlap (direct contact), FRET can occur over larger 
distances (up to ca. 100 Å). The rate of excitation energy transfer via FRET (݇ிோா்) can 
be expressed according to equation [14].   
 ݇ிோா்ሺݎሻ ൌ
ͳ
߬௙ǡ஽ ൬
ܴ଴
ݎ ൰
଺
 [14] 
In this equation, ߬௙ǡ஽  is the fluorescence lifetime of the donor in the absence of 
acceptor, and ݎ the distance between donor and acceptor. The Förster distance (ܴ଴) is 
the donor-acceptor distance at which 50% of the donor molecules relaxes via FRET. 
The energy transfer efficiency, ܧሺݎሻ, can therefore be expressed in terms of ܴ଴  andݎ , 
according to equation [15]. 
 ܧሺݎሻ ൌ ܴ଴
଺
ܴ଴଺ ൅ ݎ଺ 
[15] 
Note how the efficiency of energy transfer depends on the donor-acceptor distance to 
the inverse power of six. This strong distance dependence makes FRET an excellent 
method for measuring the proximity of ܦ-ܣ pairs. Finally, the Förster distance can be 
written as a function of the donor fluorescence quantum yield (ߔ௙ǡ஽) the orientation 
factor (ߢଶ), the overlap integral between the normalized emission spectrum of the 
donor,ܨ஽ሺߣሻ, and the molar absorption coefficient of the acceptor, ߝሺߣሻ, according 
to equation [16]. 
 ܴ଴଺ ൌ
ͻͲͲͲߔ௙ǡ஽ሺ݈݊ͳͲሻߢଶ
ͳʹͺߨହ݊ସ ஺ܰ නܨ஽ሺߣሻߝሺߣሻߣ
ସ݀ߣ [16] 
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In this equation, ݊ is the refractive index of the intervening medium (typically the 
solvent), and ஺ܰ Avogadro’s number. The Förster distance (to the power of six) is in 
other words dependent on FRET-pair specific parameters and directly proportional 
toߢଶ. The orientation factor, in turn, depends of the relative orientation between the 
transition dipole moments of the donor and acceptor and ranges from 0 (for 
perpendicular arrangement) to 4 (linearly aligned). For randomly oriented FRET-pairs, 
ߢଶ equals 2/3. 
2.4.2 Photochromism 
The photochromic reaction is central to this thesis. According to the IUPAC Gold 
Book it is defined as “a reversible transformation of a molecular entity between two 
forms, ܣ andܤ, having different absorption spectra, induced in one or both directions 
by absorption of electromagnetic radiation. The spectral change produced is typically, 
but not necessarily, of visible color and is accompanied by differences in other physical 
properties.”30 The overall process according to the above definition can be written as 
shown in reaction [17] where ݎ஺஻ and ݎ஻஺ denote the reaction rates. 
 ܣ
ݎ஺஻
֖
ݎ஻஺
ܤ [17] 
Since photochromic reactions are initiated by the absorption of light and thus are 
excited state process, the isomerization quantum yield (ߔ௜௦௢) can be defined analogous 
to equation [11], to yield equation [18];  
 ߔ௜௦௢ ൌ
͓݅ݏ݋݉݁ݎ݅ݖܽݐ݅݋݊݁ݒ݁݊ݐݏ
͓ܾܽݏ݋ݎܾ݁݀݌݄݋ݐ݋݊ݏ  
[18] 
The reaction rate ݎ஺஻ (ݎ஻஺ is defined analogously) can be expressed as the product of 
the light intensity, ܫሺߣሻ, molar absorption coefficient, ߝሺߣሻ, and ߔ௜௦௢  according to 
equation [19].  
 ݎ஺஻ ן ሾܣሿܫሺߣሻߝ஺ሺߣሻߔ௜௦௢஺஻ [19] 
For a photochromic reaction performed with a wavelength where both species ܣ and 
ܤ have non-zero molar absorption, a photostationary distribution (PSD), where ݎ஺஻ =ݎ஻஺, 
is reached. Assuming wavelength-independentߔ௜௦௢, the PSD can be written according 
to equation [20]. 
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 ܲܵܦ ൌ ሾܣሿሾܤሿ ൌ
ߝ஻ሺߣሻߔ௜௦௢஻஺
ߝ஺ሺߣሻߔ௜௦௢஺஻
 [20] 
Equation [20] is particularly useful for selecting a suitable wavelength to perform the 
photoswitching. Neglecting any wavelength dependence of ߔ௜௦௢, the isomeric ratio at 
photoequilibrium can be controlled by applying an irradiation wavelength where the 
ratio between the molar absorption coefficients of the two isomeric forms correspond 
to the desired PSD. 
2.5 Host-Guest Chemistry 
Host-guest chemistry relates to non-covalent interactions e.g. hydrogen bonding, 
hydrophobic forces, van der Waals forces, electrostatic interactions, metal coordination 
etc., where the molecular species can be regarded as discrete units and the interactions 
between them are treated statistically. In particular, host-guest chemistry describes 
binding interactions where two types of molecules denoted host (ܪ) and guest (ܩ) self-
assembles to form a supramolecular complex, e.g. ܪ̷ܩ.†† Included in this section are 
the two most common ܪǣܩ  binding stoichiometries; 1:1, and 1:2. Common host 
molecules include cucurbiturils,31 cyclodextrins,32,33 and porphyrins34 to mention a few.  
Reversible enzyme-ligand interactions (e.g. Type I, II, and III kinase inhibition, see 
section 4.4) can also be treated as host-guest binding events, and therefore, some 
theoretical aspects on this topic is included in this section. The defining parameter of 
host-guest binding is the equilibrium binding constant (ܭ), representing the strength of the 
complex formation. It can be assessed by observing changes in equilibrium complex 
concentration(s) in the presence of varying concentrations of the guest. 
Experimentally, this is most often achieved through spectroscopic titration 
experiments.35 
2.5.1 1:1 Binding Stoichiometry 
The most basic complexation is where one guest binds to one host. This is referred to 
as 1:1 complex formation, which can be written according to reaction [21]. 
 ܪ ൅ ܩ
݇ଵ
֖
݇ିଵ
ܪ̷ܩ [21] 
                                                          
†† Here, the @-sign represents the non-covalent, reversible nature of the complex interaction. 
15 
Here, ݇ଵ  and ݇ିଵare the rate constants for the forward and backward reaction, 
respectively. In the case of 1:1 binding, ܭଵଵ is defined according to equation [22]. 
 ܭଵଵ ൌ 
ሾܪ̷ܩሿ
ሾܪሿሾܩሿ ൌ 
݇ଵ
݇ିଵ 
[22] 
For a 1:1 complex, the concentration of unbound host and guest can be expressed in 
terms of the total concentration of host (ሾܪሿ௧௢௧) and guest (ሾܩሿ௧௢௧) according to the 
mass balance equations [23] and [24]. 
 ሾܪሿ௧௢௧ ൌ ሾܪሿ ൅ ሾܪ̷ܩሿ [23] 
 ሾܩሿ௧௢௧ ൌ ሾܩሿ ൅ ሾܪ̷ܩሿ [24] 
The equation system consisting of [22], [23], and [24] has one relevant solution 
forሾܪ̷ܩሿ, this is shown in equation [25]. 
 
ሾܪ̷ܩሿ ൌ  ଵଶ ቀሾܩሿ௧௢௧ െ ሾܪሿ௧௢௧ ൅
ଵ
௄భభቁ െ
ටቀሾܩሿ௧௢௧ െ ሾܪሿ௧௢௧ ൅ ଵ௄భభቁ
ଶ ൅ Ͷሾܪሿ௧௢௧ሾܩሿ௧௢௧  
[25] 
Since ሾܪሿ௧௢௧ and ሾܩሿ௧௢௧ are generally known, equation [25] implies that if the binding 
situation is such that the complex formation is exclusively of 1:1 character, and ሾܪ̷ܩሿ 
can somehow be monitored, ܭଵଵ is the only unknown parameter and can easily be 
determined. Conversely, if the binding constant is known, the equilibrium 
concentration of all species in solution (via equations [23] and [24]) can readily be 
calculated. 
2.5.2 1:2 Binding Stoichiometry 
The 1:1 stoichiometry can be expanded to describe binding interactions where the host 
can bind two guests or vice versa.‡‡ In 1:2 binding, two dynamic equilibria (reaction [26]) 
are maintained. Thus, two binding constants (equations [27] and [28]) are needed to 
characterize the equilibrium concentrations. 
                                                          
‡‡ Which of the molecular species is denoted host and which is denoted guest is arbitrary from a 
theoretical point of view, 2:1 binding stoichiometry can be defined analogously to 1:2 binding. 
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 ܪ ൅ ʹܩ
݇ଵ
֖
݇ିଵ
ܪ̷ܩ ൅ ܩ
݇ଶ
֖
݇ିଶ
ܪ̷ܩଶ [26] 
 ܭଵଵ ൌ 
݇ଵ
݇ିଵ ൌ
ሾܪ̷ܩሿሾܩሿ
ሾܪሿሾܩሿଶ ൌ
ሾܪ̷ܩሿ
ሾܪሿሾܩሿ  
[27] 
 ܭଵଶ ൌ 
݇ଶ
݇ିଶ ൌ
ሾܪ̷ܩଶሿሾܩሿ
ሾܪሿሾܩሿଶ ൌ
ሾܪ̷ܩଶሿ
ሾܪሿሾܩሿ  
[28] 
The mass-balances in the case of 1:2 binding are defined analogously to the 1:1 binding, 
as shown in equations [29] and [30].  
 ሾܪሿ௧௢௧ ൌ ሾܪሿ ൅ ሾܪ̷ܩሿ ൅ ሾܪ̷ܩሿଶ [29] 
 ሾܩሿ௧௢௧ ൌ ሾܩሿ ൅ ሾܪ̷ܩሿ ൅ ʹሾܪ̷ܩሿଶ [30] 
For the equation system composed of equations [27]-[30] above, the concentrations 
cannot be solved analytically. Instead, iterative algorithms must be employed to solve 
the resulting cubic equation [31]. 
 
ሾܩሿଷܭଵଵܭଵଶ ൅ ሾܩሿଶሺܭଵଵሺʹܭଵଶሾܪሿ଴ െ ܭଵଶሾܩሿ଴ ൅ ͳሻሻ ൅
ሾܩሿሺܭଵଵሺሾܪሿ଴ െ ሾܩሿ଴ሻ ൅ ͳሻ െ ሾܩሿ଴ ൌ Ͳ  
[31] 
The theoretical framework for host-guest binding situations can easily be expanded to 
account for more complicated stoichiometries, as long as equilibrium expressions and 
mass-balances can be defined, to match the number of unknown parameters. Once 
these systems of equations are in place, obtaining numerical solutions is also generally 
feasible. What typically proves more demanding, however, is to design experiments to 
accurately determine the involved binding constants, particularly in cases where the 
physicochemical observables (e.g. absorption spectra) of the different complexes in 
solution are similar. 
2.5.3 Competitive Enzyme Inhibition 
Non-covalent competitive enzyme inhibition (e.g. Type I and Type II kinase inhibition, 
section 4.4) can be treated as a series of connected equilibria where the enzyme-
catalyzed product (ܲ) formation in the presence of substrate (ܵ) and competitive 
inhibitor (ܫ), can be written according to reaction [32]. 
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 ܧ̷ܫ ൅ ܵ
݇ି௜
֖
݇௜
ܧ ൅ ܵ ൅ ܫ
݇௦
֖
݇ି௦
ܧ̷ܵ ൅ ܫ
݇௣
՜ܧ ൅ ܲ ൅ ܫ [32] 
Assuming that the enzymatic reaction without inhibitor present follows Michaelis-
Menten kinetics, the rate of substrate turnover ( ଴ܸ) can be derived as a function of the 
maximum rate ( ௠ܸ௔௫), and the substrate- and inhibitor concentrations according to 
equation [33]. 
 ଴ܸ ൌ ௠ܸ௔௫
ሾܵሿ
ܭ௠ሺͳ ൅ ܭ௜ሾܫሿሻ ൅ ሾܵሿ 
[33] 
Here, ܭ௠  is the Michaelis-Menten constant, i.e. the substrate concentration at which 
଴ܸ  = ௠ܸ௔௫/2 in the absence of inhibitor, and ܭ௜ ൌ ݇௜ ݇ି௜Τ  is the inhibitor binding 
constant. It is common practice to report ܫܥହ଴ -values as a measure of inhibitor 
potency. The ܫܥହ଴-value is defined as the inhibitor concentration at which the enzyme 
activity is suppressed 50% in vitro. For competitive inhibitors, it can be related to the 
inhibitor-to-enzyme binding constant (ܭ௜) according to the Cheng-Prusoff equation:36  
 ܫܥହ଴ ൌ ܭ௜ ൬ͳ ൅
ሾܵሿ
ܭ௠൰ 
[34] 
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3 Methodology 
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This chapter presents the main experimental techniques used in the papers comprising 
this thesis. These are without exceptions spectroscopic techniques, and therefore rely 
on light-matter interactions. The underlying theoretical considerations are described in 
the previous chapter 2. 
3.1 Absorption Spectroscopy 
In this thesis, absorption spectroscopy refers to the steady-state experimental technique. 
As such, it records the average absorption of an ensemble of randomly oriented 
molecules in solution as a function of incident light wavelength. Figure 4 shows the 
experimental setup of an absorption spectrometer. 
 
 
 
Figure 4. Schematic layout of a typical absorption spectroscopy setup. The beam-path, 
monochromator, cuvette sample compartment, and detectors are specified. 
By measuring the light intensity before and after the sample, a measure on the 
absorption as a function of the wavelength of the probing light is obtained according 
to equation [35]. 
 ܣሺߣሻ ൌ  ൬ܫ଴ሺߣሻܫሺߣሻ ൰ 
[35] 
Here, ܣሺߣሻ  is the wavelength-dependent absorption and ܫ଴ሺߣሻ  and ܫሺߣሻ  the light 
intensities before and after the sample, respectively. An absorption spectrum is collected 
by probing the absorption while scanning the sample with a range of wavelengths. 
Absorption spectroscopy, although basic in its experimental layout, is a powerful and 
versatile technique for studying molecules in solution. An important reason for this is 
the straightforward relationship between absorption and molar concentration (ܥ ) 
provided by the Lambert-Beer law, as shown in equation [36]. 
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 ܣሺߣሻ ൌ ߝሺߣሻܥκ [36] 
Here, κ is the sample path length (Figure 4) and ߝሺߣሻ the molar absorption coefficient 
(typically expressed in M-1cm-1). Molar absorption is an additive property in the sense 
that if N absorbing species is present in solution, the molar absorption coefficient-
weighted concentration of each species make up the total absorption according to 
equation [37]. 
 ܣሺߣሻ ൌ κ෍ߝ௝ሺߣሻܥ௝
ே
௝
 [37] 
For studying photochromic reactions, UV/vis absorption spectroscopy (typically 
probing the 200 - 800 nm wavelength region) is an exceptionally suitable technique as 
it provides a convenient means of monitoring the isomerization while requiring small 
amounts of sample. 
3.2 Fluorescence Spectroscopy 
Fluoresence spectroscopy is a collective term for a number of techniques probing the 
emissive properties of molecules. As in the preceding description of absorption 
spectroscopy, fluorescence spectroscopy herein refers to the steady-state technique, i.e. 
the average emission from an ensemble of randomly oriented molecules in solution. 
Figure 5 shows the principal components of a typical experimental setup. 
 
 
Figure 5. Schematic layout of a typical fluorescence spectroscopy setup. The beam-path, 
monochromators, cuvette sample compartment, and detectors are specified. 
Two key modes of operation in steady-state fluorescence spectroscopy are emission- and 
excitation mode. They differ in the way the monochromators are operated. In emission 
mode, the excitation monochromator is fixed, while the emission monochromator is 
scanned over the different wavelengths. Thus, information on the relative fluorescence 
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intensities of the emitted light is obtained. The result is presented as an emission spectrum, 
displaying fluorescence intensities as a function of emitted wavelengths. In excitation 
mode, the roles of the monochromators are reversed, providing information on the 
absorptive origin of the emitting species. Typically, emission is collected at a right angle 
to the excitation light§§ in order to minimize the amount of light from the excitation 
source reaching the detector.  
With this setup, fluorescence can be used as a highly sensitive analytical tool for 
probing e.g. changes in the microenvironment of a fluorophore. The absolute intensity 
ratio of incident vs. emitted light is strongly instrument-dependent and therefore rarely 
presented in the literature. Instead, the fluorescence intensity of a compound is 
typically referenced to existing standards and presented as a fluorescence quantum 
yield. A comprehensive description of various fluorescence-based techniques and their 
applications can be found in the textbook “Principles of Fluorescence Spectroscopy” 
by Lakowicz.37 
3.3 Confocal Microscopy 
Fluorescence microscopy is an imaging technique where emission from added or 
naturally existing fluorophores is observed through an optical system to create 
magnified images. This differs from conventional wide field microscopy where 
contrast instead is obtained through sample differences in e.g. opacity or refractive 
index. In fluorescence microscopy, an excitation source is needed to excite the 
fluorophores. Lasers are typically used for this purpose as they produce monochromic 
light while allowing regulation of the intensity. A schematic of a laser scanning confocal 
microscope (LSCM) setup is shown in Figure 6. 
                                                          
§§ Front face detection, collecting emitted light at a very small angle to the exciting light beam, can be 
used for highly concentrated samples or films. 
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Figure 6. Schematic representation of the principles of confocal microscopy. Note how only 
light from the focal plane of the sample (solid black line) reaches the detector. 
Most LSCMs in life science today are operated in so called “epi-mode”, meaning that 
the emission is observed from the same side as the incident excitation originated. This 
means that excitation light and emitted light partly travels in the same beam path, 
through the same components. In particular, the objective for the exciting light becomes 
the condenser for the emitting light. Further components in the confocal setup includes 
the dichroic mirror, which reflects excitation light while transmitting emitted light; the 
emission filter(s), which further excludes remaining excitation light and enables multiple 
emission output channels, and the detector. What actually makes the microscope 
“confocal”, is the pinhole aperture. By placing a pinhole in a conjugate plane to the 
sample focal plane, out-of-focus fluorescence is blocked from the detector and only 
light originating from the focal plane is detected. The “scanning” part of LSCM refers 
to the function of the scanning mirrors (not shown in Figure 6). They are incorporated in 
the beam-path and are responsible for directing the excitation volume to achieve point-
by-point illumination of the sample, facilitating generation of the 2D emission intensity 
histogram that is the image. The resolution of an LSCM is diffraction limited,*** 
however several super resolution techniques (e.g. stimulated emission depletion, 
STED)38 are advancements stemming from the confocal setup. Readers interested in a 
more thorough description of confocal microscopy in biological imaging are referred 
to the comprehensive textbook “Handbook of Biological Confocal Microscopy” by 
Pawley.39 Related to this thesis, confocal microscopy was used to image bio-structures 
                                                          
*** The theoretical limit (the Abbe diffraction limit) for what light microscopy can resolve is around 
250 nm. 
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(cells and neurons) in Papers I and VI, as well as for delivering in situ photoswitching 
stimulus in Paper I. 
  
25 
 
4 Controlling Biology with Light 
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As briefly mentioned in the introduction to this thesis, two fundamental components 
are required to realize a photocontrolled system. The first is an optical system 
producing light. Several properties inherent to light makes it superior as external 
stimulus. (1) Light propagates with a speed of ca. 300 000 km/s, which means that the 
application intended for control can be more or less instantly triggered. (2) Light can 
be focused to very small volumes. There are microscopy techniques in use where the 
excitation focal volume is controlled with femtoliter (10-15 L) precision, allowing for a 
highly localized site of activation. (3) Under certain conditions, light is bio-orthogonal, 
meaning that it has minimal effect on the native systems of the body. It is also waste-
free, as no chemicals are added or produced.  
For light to be able to interact with molecules inside the body, a fundamental 
requirement is that it can sufficiently penetrate the skin and underlying tissue.††† Light-
scattering and overlapping absorption from heme-groups in blood severely limits the 
penetration depth of light with wavelengths below 650 nm. For longer wavelengths 
(λ > 900 nm), absorption attributed to vibrational modes of water molecules becomes 
a limiting issue. This effectively creates a window where interfering absorption is 
minimal, called the therapeutic optical window.5,40,41 It should be noted, however, that most 
of the photocontrolled systems published in the literature today (including a majority 
of the papers this thesis is based on) are operated using light with wavelengths outside 
the therapeutic optical window. Because of this (at least for applications in tissue 
samples), they have to be regarded as proof-of-principle studies. Several techniques 
(e.g. multiphoton-excitation, and photon upconversion), can be applied to overcome 
the limitations imposed by the optical window. 
The second requirement in a photocontrolled system is the photoresponsive 
component.6,10,11 There are two main classes of photoresponsive compounds used in 
this line of research – photoswitches and photocages. One may also include 
photosensitizers in this category, in particular photosensitizers for generating reactive 
oxygen species, as utilized in photodynamic therapy (PDT). PDT has proven highly 
successful for treating a range of medical conditions (e.g. superficial cancers42) and is a 
prime example of a phototriggered technique that has made it far into clinical practice. 
In this thesis, PDT is omitted from further discussions mainly because the effect 
controlled by light invariably is of non-specific kill/no kill character.  
Based on the photoswitchable and photocaged building blocks, a number of 
strategies for obtaining photonic control of biological systems have been devised. As 
expected when trying to summarize a rapidly evolving research field, absolute 
distinctions are sometimes hard to make out. Nevertheless, for the purpose of this 
                                                          
††† A complementary method circumventing this requirement is the endoscopic use of optical fibers 
for direct light-exposure. However, this compromises the overall non-invasive character attributed to the 
photocontrolled approach. 
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chapter, an organization inspired by that proposed in a recent publication by Kramer 
has been adopted (Figure 7).43 In that work, the strategies for obtaining optical control 
over native signaling proteins are exemplified for the field of neuroscience. 
 
 
Figure 7. A schematic overview of the strategies for controlling biological systems. 
The first branching in Figure 7 separates the purely genetic approach that is 
optogenetics from the optochemical genetics approach. Optogenetics, as developed by 
among others Miesenböck44 and Deisseroth45, is based on genetically introducing light-
sensitivity to biomolecules and cells, typically via expression of light-responsive opsin-
based proteins, e.g. channelrhodopsins.46 This technique has evolved immensely since 
its discovery and a testament to its massive impact is the appointment of optogenetics 
as Nature Methods’ “Method of the year” in 2010.47 It was also recognized in a 
“Breakthrough of the decade” article in Science Magazine from the same year.48  
In contrast to optogenetics, optochemical genetics (as coined by Trauner and 
co-workers in 2011)9 relies on exogenous introduction of synthetic photoresponsive 
units. The second branching in Figure 7 maps out the two main strategies for this; 
optogenetic pharmacology and photopharmacology.‡‡‡ In optogenetic pharmacology, 
a photosensitized biomolecule is achieved by covalently attaching the photoresponsive 
unit to a genetically tagged protein. In practice, this is most often done by attaching 
azobenzene photoswitches to genetically encoded thiol groups at the site of interest, 
resulting in so-called photochromic tethered ligands.49,50 The bioconjugate will in this 
way be addressable by light, thus combining the absolute selectivity of genetic design 
with the resolving power of light. Both optogenetics and optochemical genetics have 
had a tremendous impact on, in particular, neuroscience. However, both strategies 
suffer from the necessity of having to genetically modify the target, which typically 
requires tedious viral gene-infusion protocols, hampering the general applicability of 
these approaches.  
The remaining category in Figure 7 is photopharmacology.6 It differs from the 
previously discussed methods, as no genetic manipulation is required. Neither does it 
                                                          
‡‡‡ It seems that “photophamacology” and “optopharmacology” is used interchangeably in the literature. 
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lead to a permanently modified target, due to the non-covalent nature of the 
interaction. To a large extent, this makes photopharmacology similar to traditional 
pharmacotherapy, but (as pointed out in the introduction to this thesis) with the 
exceptional added value of external photocontrol. Because the targeted structures and 
systems are completely unmodified, an additional advantage is that the observed effects 
will be those of a truly native system. Compared to the genetics-based techniques, 
which have existed since the turn of the millennium, photopharmacology is 
significantly older, with pioneering contributions presented in the 1960s and 1970s.51,52  
The above organization mainly describes how light-control can be achieved on a 
whole-cell or even organism level. In addition to this, there is a tremendous amount of 
research done on simplified models, and/or synthetic analogs of isolated biomolecules. 
A well-explored strategy for elucidating basic functions of biomolecules and how it can 
be controlled by light is by synthetic incorporation of photoswitchable or caged motifs 
into biomolecules.8 With this scheme, bio-relevant events such as the duplex-formation 
of DNA,53-55 protein folding,56-58 and RNA hybridization59,60 have been controlled with 
light. 
The content of this thesis in relation to the above classification system stretches 
from basic photochromic research (Papers II, III, and IV) to photopharmacology 
(Papers I, V and VI). It could be argued that the pursued drug release systems presented 
in Papers II and IV (upon successful implementation in a biological context) would 
qualify to the photopharmacology category. However, no such attempt is presented 
here. 
4.1 Molecular Photoswitches 
In this section, the general principles of molecular photoswitches and some reflections 
relating to their use are described. The detailed function and characteristics of the three 
types of photoswitches used in this thesis (spiropyrans, azobenzenes, and 
dithienylethenes) is expanded on in the contained subchapters. 
Molecular photoswitches are compounds with the rare ability to utilize excitation 
energy from light to reorganize chemical bonds and relax into a stable conformer with 
a different structural arrangement. In many cases, this isomerization can be reversed by 
exposing the sample to light of a different wavelength, targeting the new conformer.§§§ 
In this way, one molecule can be reversibly isomerized between two different forms 
using nothing but photonic stimuli. In terms of executing a specific task, the challenge 
is then to design the photoswitch in such a way that one isomer induces the desired 
                                                          
§§§ The theoretical on photochromism was covered in the previous section 2.4.2. 
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effect, while the other does not. Successful molecular design according to this criteria 
would then allow for a photoreversibly controlled application. 
 
Figure 8. The principle of photoswitchable target affinity. a) The photoswitch can be reversibly 
isomerized between two forms with light. Due to the difference in molecular shape, only one 
isomer is able to bind to the target. b) A localized effect can be selectively triggered by exposing 
a subset of the target population to light. Changing the exciting light-frequency to ߥଵ reverses 
the binding event. 
There exists a limited number of photoswitchable core-structures (e.g. azobenzenes, 
diarylethenes, spiropyrans, spirooxazines,61 etc.), each with its own characteristic set of 
properties. In many cases, however, substituents can be introduced without 
compromising the overall photoswitching ability of the compound, allowing for tailor-
made photoswitches and/or insertion of the photoswitchable moiety into larger 
molecular constructs8. This versatility has led to the development of numerous 
photoswitchable molecules and systems for use in biology.4,6-8,10,11,62 
For application in a biological contexts, a thorough understanding of the 
physicochemical properties of the photoswitch in aqueous solution is key. Some 
important questions to address regarding photoswitch design are discussed below. (1) 
To what extent can light enrich the sample in the respective isomeric form? For optimal 
effect, it is often highly desirable to be able to quantitatively convert the sample 
between the two forms. However, due to overlapping absorption (in particular for the 
UV induced process), this is rarely possible. Instead, a photostationary distribution 
(PSD) for the respective photoinduced reaction is reached. The PSD reflects the 
isomeric composition at photoequilibrium (section 2.4.2 elaborated on this), which in 
turn defines the action spectrum of the photoswitch, i.e. the response-extremes between 
which the photo-operated system can exhibit control. (2) How stable are the two 
isomeric forms toward thermal (dark) isomerization? Typically, a bistable compound is 
wanted, i.e. a compound that, once photoswitched, retain the isomeric composition 
over time in the dark until photonically addressed again. It should be noted, however, 
that there are also applications which instead rely on the exact opposite, i.e. 
spontaneous deactivation of the photoswitch.63 (3) Does the compound degrade in its 
intended environment? Photoswitch degradation can for instance be induced by 
solvent molecules64 or cell reductants, e.g. glutathione.65 The rate of degradation as well 
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as the nature of the potential degradation products are of importance, in particular for 
extended use in aggressive environments. (4) Is the photoswitch degraded by light? 
Photodegradation (or photofatigue) presents another potentially limiting factor that needs 
to be considered. 
4.1.1 Spiropyrans 
The spiropyran photoswitch consists of a chromene connected to an indoline moiety 
via a spiro-carbon. The resulting molecule is the ring-closed spiro-form (SP). A general 
spiropyran structure and its photochromic reaction to the colored merocyanine form 
(MC) is shown in Figure 9. 
 
Figure 9. Photonic and thermal interconverison pathways of a general spiropyran photoswitch. 
The by far most commonly used spiropyran is the spiro[2H-1-benzopyran-2,2’-
indoline] (BIPS), and in particular the nitro-substituted 6-nitro-BIPS (Figure 9, 
R1 = Me, and R2 = NO2). Theoretical investigations66 and spectroscopic studies67-69 of 
how the photoisomerization of spiropyrans proceeds have been presented. In general 
terms, an initial photo-induced cleavage of the C1-O bond is followed by a cis/trans 
isomerization (over the C2-C3 bond) in the course of SP → MC conversion. This 
transformation brings about a large shift in dipole strength from ca. 2-5 D to 20 D.69 
With the isomerization follows substantial steric changes as the molecule is 
transformed from the bulky SP to the planar, electronically conjugated MC. This 
extended conjugation is responsible for the intense visible absorption of MC (Figure 
10). 
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Figure 10. Absorption spectra of the SP (solid black), SPH+ (dashed black), MC (solid red) and 
MCH+ (dashed red) forms of a spiropyran in water. Here, R1 = C3H6NMe3Br, R2= NO2, as used 
in Paper III. 
Due to the zwitterionic nature of the MC form, it is stabilized water. Therefore (as 
opposed to organic solvents), an SP ֖ MC thermal equilibrium with a significant 
contribution from MC is established in water at room temperature.67 The rate with 
which the thermal equilibrium is established in water varies with substituents, but 
typically occurs on the hour timescale. Both the SP- and MC-forms can be protonated 
in water to yield SPH+ (pKa ca. 0-3) and MCH+ (pKa ca. 3-5), respectively (Paper III). 
The protonation has been proposed to occur on the indoline nitrogen and phenolate 
oxygen on SP and MC, respectively, and conveys changes in both absorption spectra 
and photochromic properties.70 While SPH+ is neither thermo- nor photochromic, the 
MCH+ → SP interconversion can be triggered with visible light. The tunability of 
acidity constants (via substitution, see Paper III) and the general acidochromic features 
of spiropyrans makes them eligible for combinatory applications where acid and light 
inputs can be combined to condition for instance energy transfer or DNA binding.71,72 
On the negative side, the spiropyran photoswitch is known to suffer from hydrolytic 
instability, which seriously limits extended use in aqueous solutions.64  The hydrolysis 
has been proposed to proceed as a retro-aldol reaction initiated by a nucleophilic attack 
on C3 of MC. The MCH+ on the other hand, is completely stable toward hydrolysis. 
This is discussed in further detail in the appended Paper III, where it is concluded that 
in the pH-range 5-9, water (rather than hydroxide ions) is the hydrolysis-inducing 
reactant, and that the phenolate oxygen of MC plays a key role in the hydrolytic 
mechanism. 
Compared to the main body of photoswitchable compounds, the spiropyran 
stands out due to the exceptionally large shift in polarity and steric profile. In particular, 
the bulky-to-flat rearrangement upon SP → MC isomerization has seen it included in 
several photoreversible DNA-binding applications by the group of Andréasson, 
32 
typically utilizing the intercalating properties of the open form.71,73-75 Its properties 
when covalently linked to the phosphate backbone of DNA has also been reported on, 
although with mixed results in terms of photoactivity.76-78 Other biological targets 
include RNA, the binding to which was photoreversibly controlled by the group of 
Deiters79 and Tian.80 There have also been reports on covalent modification of channel 
proteins to afford light-controlled pore opening, and content release.81 This reversible 
“nano-valve” effect was proposed to be due to disruption of the helix arrangements in 
the protein due to electrostatic repulsion caused by the MC form. As for triggering 
SP → MC isomerization through the optical therapeutic window, Marriott and co-
workers showed that two-photon induced isomerization to the fluorescent MC isomer 
could be triggered with 720 nm and used for Optical Lock-In Detection imaging in live 
Xenopus neurons.82 
4.1.2 Azobenzenes  
The archetypical azobenzene consists of two azo-bridged benzene rings, and exists in 
two isomeric forms; the thermally favored E-form and the Z-form, as shown in Figure 
11a. Azobenzenes form one of the largest class of photoswitchable molecules and for 
biological applications, it is by some distance the most frequently used.49,83 The reasons 
for this likely include the convenient “straight-to-bent” structural change, 
comparatively easy synthesis, and fatigue resistant photoswitching.84 
a) b) 
Figure 11. a) Photonic and thermal reactions of the azobenzene photoswitch, emphasizing the 
difference in end-to-end distance of the isomers. b) UV/vis absorption spectra of the 
azobenzene-derived I3 in water, as used in Paper V (see Figure 34a on page 63 for structure). 
The thermally stable E-form (black line) can be photonically converted to the Z-form (red line, 
87% Z-form) using UV light. 
The absorption spectrum of the near-planar E-form is characterized by a strong ߨ-ߨכ 
and weak ݊-ߨכtransition (Figure 11b, black line at ca. 350 nm and 450 nm, respectively) 
Excitation into the former band typically allows for substantial Z-form enrichment. 
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The resulting Z-form adopts a bent conformation, with the phenyl ring at a 55º angle 
to the plane of the azo-group.85 With the isomerization follows an increase in dipole 
strength from ca. 0 to 3D, and a decrease in end-to-end distance (Figure 11a, ca. 3.5 Å 
difference).85 The Z-form reverts thermally to the E-form, but this reaction can also 
be triggered with light, targeting the ݊-ߨכ transition of the Z-isomer (Figure 11b, red 
line at ca. 450 nm). Theoretical-86 and experimental studies87 have been performed to 
elucidate how the photoinduced E → Z isomerization proceeds, resulting in several 
mechanistic explanations.83 
The thermal instability toward isomerization associated with the Z-form is often 
described (along with UV operation) as the main limiting characteristic of azobenzenes. 
This rate can be rationalized based on the proposed dipolar transition state.88 
Therefore, it can be said with some generality that the rate of thermal Z → E 
isomerization increases with solvent polarity.89 Introducing substituents on the phenyl 
rings can drastically affect the rate of this reaction.90 Stabilization of the Z-isomer can 
for instance be achieved by introducing substituents in the ortho-position, as 
demonstrated by e.g. the groups of Hecht91,92 and Woolley.93,94 This was also shown to 
separate the normally overlapping ݊-ߨכ bands of the E- and Z-isomers, allowing for 
near-quantitative photoswitching in both directions. 
Regarding two-photon techniques for photoswitching azobenzenes using for 
instance red light, the cross-section for two-photon absorption of both isomers is 
generally small (0.1-5 GM).95 One strategy for overcoming this limitation is to attach a 
two-photon absorption sensitizer to the azobenzene, which then facilitates 
photoswitching by transferring excitation energy to the azo switching unit in an 
antenna-like fashion, as shown in a dendrimeric sample by Jiang et al.96 This concept 
was expanded on in a recent study by Izquierdo-Serra et al. where light-control over 
the action of a glutamate receptor in live cells on the basis of two-photon azobenzene 
switching was achieved.97 
The numerous reports on the use of azobenzenes in biological settings have been 
extensively reviewed and will not be covered in detail here.49,56,83,94,98 In this thesis, the 
azobenzene switching motif was used to gain photoswitching ability of a small 
molecule effector (kinase inhibitor, Paper V), in line with the photopharmacology 
approach previously described in this chapter. For introducing photoreversible steric 
bulk in small-molecules, the azo unit is a widespread choice. A testament to the general 
popularity of this type of structural modification is the term “azologization” recently 
coined by Trauner and co-workers.99 Photoswitchable small-molecule effectors have 
in this way been prepared to control the activity of a multitude of biological 
targets52,99-102 
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A noteworthy drawback regarding the use of azobenzenes in biological 
environments is the tendency of the azo bridge to be reduced in the presence of thiols, 
e.g. glutathione.65 
4.1.3 Dithienylethenes  
Dithienylethenes (DTEs) are a subgroup of the broader chemical class diarylethenes 
(DAEs), which consist of two aryl groups linked by an ethene bridge. In general terms, 
the DAE photoswitches are renowned for their exceptional thermal bistability, high 
photoswitching yields, and substantial changes in energetics.103-106 The overall steric 
changes upon photoswitching, however, are small. One example of a DAE is stilbene, 
having two ethene-connected phenyls. **** The thermally stable E-form of stilbene can 
be photoswitched to the Z-form, which upon further photonic excitation can undergo 
a 6ߨ-electrocyclic ring-closing reaction with subsequent oxidation to yield the stable 
product phenantrene (Figure 12).107 
 
Figure 12. Photothermal reactions of stilbene, leading to the irreversible formation of 
phenantrene. 
By introducing methyl groups in the 8- and 14-positions of stilbene however, the 
irreversible oxidation reaction can be suppressed, allowing for bidirectional 
photoswitching between the ring-open and ring-closed form. Furthermore, 
incorporating heteroatoms (most often sulphur or nitrogen) in the aromatic ring 
systems, lowers the aromatic stabilization energy of the open form.108 This effectively 
reduces the rate of thermal ring-opening and therefore increases the thermal stability 
of the closed form, yielding a bistable photoswitch. Finally, to prevent photoinduced 
Z → E isomerization from competing with the photocyclization reaction, the ethene 
group is incorporated into a cycloalkene structure, e.g. a maleimide109 or 
perfluorocyclopentene.110 The structure and absorption spectra of a typical DTE 
photoswitch are shown in Figure 13. 
                                                          
**** Although formally diarylethenes, stilbenes are often considered as a separate class of photoswitches. 
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a) b) 
Figure 13. a) Structure and photoisomerization scheme of a general DTE photoswitch. b) 
UV/vis absorption spectra of the open (black line) and closed (red line) form of a DTE in 
toluene. Here, R1 = R2 = C5H4N (pyridine), R3 = F6, as used in Paper IV. 
The propeller-shaped open isomer absorbs light mainly in the UV region (Figure 13b, 
black line), with electron density localized mostly on the two thiophene rings. Exposing 
the open form to UV light stimulates the ring-closing reaction, resulting in the more 
or less planar closed form. Due to the extended electronic conjugation in the ring-
closed isomer, the absorption band is dramatically red-shifted, leading to intense visible 
light absorption (Figure 13b, red line). The isomerization reaction can be rationalized 
on the basis of the Woodward-Hoffman orbital symmetry selection rules,111 which 
means that only open isomers with the thiophene rings in an antiparallel arrangement 
(the photoactive antiparallel arrangement is implied in Figure 13a) can undergo the 
symmetry-allowed conrotatory photocyclization reaction. As the energy barrier for the 
parallel ֖ antiparallel reorganization in the open isomer generally is low, the two 
conformers exist in a racemic mixture in solution, why the quantum yield of ring-
closing is limited to 0.5. However, asymmetric DTEs (R1 ്  R2) or stereogenic 
substituents can shift this equilibrium, to increase the ring-closing quantum yield.109,112 
There have also been reports on the use of chiral binding strategies (e.g. using DNA113 
or cyclodextrins114) to achieve enantiomeric excess upon ring-closing. The 
cycloreversion reaction is stimulated by visible light, which completely converts the 
sample to the open isomer, albeit with significantly lower quantum yield. For a 
comprehensive description of the fundamental properties and recent developments of 
DTEs, the interested reader is referred to the very recent review by Irie.104 
In this thesis, the exploited attribute of the DTE is the change in conformational 
flexibility – the open form being significantly more flexible than the ring-closed ditto. 
We used this to control the DTE binding mode to a Zn-porphyrin dimer, and thereby 
realize phototriggered drug release (Paper IV).  
As for use in biology, DTEs are not as common as e.g. the azobenzene or 
spiropyran. This is likely due to its relatively recent discovery,115 possibly in 
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combination with the limited change in geometry upon photoswitching (which 
arguably is the most attractive feature for biological applications), and lagging 
development of water soluble derivatives. That said, there are still plenty of examples 
of DTEs used in biological applications, e.g. as fluorescent probes,116,117 
photoswitchable inhibitors,118,119 and even as a regulator of paralysis in live C. 
Elegans.120 DTE-type switching units have also been synthetically incorporated into 
biomolecules, for instance DNA,121,122 by the groups of Wagenknecht and Jäschke. In 
the latter work, the DNA duplex melting temperature and transcription were 
controlled by photoswitching a DTE-derived pyrimidine nucleotide.122 
4.2 Photocaging 
Photocaging (or just caging) refers to the method of covalently linking 
activity-compromising photocleavable groups to molecules and thereby gaining 
photonic control over their original function.4,10-16 An unfortunate (yet common) 
metaphoric misconception regarding the terminology is that “caged” implies a 
geometrical confinement of the active molecule, for instance in cage-like inclusion 
complexes. This, however, is normally not the case. Figure 14 shows a schematic of 
the concept of caging. 
 
Figure 14. The concept of caging and decaging. a) Caging: Synthetic efforts yield the activity-
compromised, photoresponsive compound. The presence of the caging group prevents 
interaction with the target. Decaging: Irradiation breaks the photolabile linker, restoring the 
active molecule. b) A localized effect can be achieved by exposing a subset of the target 
population to light. 
As seen in Figure 14, once the active compound has been liberated, there is no way of 
photonically regenerating the caged (inactive) form. This irreversibility is the main 
difference between caging and the previously described photoswitching approach. 
The strategy for designing caged compounds typically departs from a known 
bioactive molecule or binding motif and focuses either on introducing steric bulk 
and/or in other ways disrupting key affinities between the active compound and its 
target. This approach has been highly successful and produced a large number of 
photocontrolled compounds, primarily within the field of cell biology.10,11,13,14,123 The 
first reports date back to 1977 and the work of Engels and Schlaeger in which an 
37 
o-nitrobenzyl caging group was attached to the phosphate group of cAMP.51 One year 
later, adenosinetriphosphate (ATP) was caged by Kaplan et al. This work was also 
where the expression “caging” was coined.124 Since then, a number of important 
biomolecules have been caged, including; glutathione,125 glutamate,126 biotin127 and 
γ-aminobutyric acid (GABA).128,129  
Regarding the choice of photolabile group, structural variants of nitroaryl- and 
coumarin-type caging groups seem to be the most widespread in the literature. In 
particular, dimethoxy-substituted o-nitrobenzyls (e.g. 6-nitroveratryloxycarbonyl, 
NVOC, a derivative of which was used in the appended Paper VI) finds regular use.11,16 
The mechanism for NVOC-decaging has been studied by computational means as well 
as transient absorption spectroscopy.130,131 A proposed mechanism is shown in Figure 
15.  
 
Figure 15. Mechanism of the photoinduced decaging of NVOC-functionalized 
compounds.130,131  The compound to be released is indicated as X, while PT denotes a solvent-
mediated proton transfer. 
Factors to consider when selecting caging groups include molar absorption coefficient 
and quantum yield of photolysis, as these are key parameters for the overall rate of the 
release. It is also preferable if the release event can be triggered with light sufficiently 
low in energy (preferably above 350 nm) to avoid potential damage to the biological 
matrix or the active compound itself.15,16 Caging groups from the o-nitrobenzyl family 
typically exhibit red-shifted absorption when substituted with electron-withdrawing 
substituents such as methoxy groups. There are also several recent examples where 
decaging has been achieved through the therapeutic optical window using e.g. two-
photon excitation,128,129,132,133 or via photon upconversion strategies.134,135  
Looking at the concept of caging as such, a few general issues require attention; 
(1) Decaging not only liberates the active compound, but also the caging group. This 
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may or may not be a problem for the intended application, depending on the reactivity 
of the caging group toward the target and/or surrounding tissue. Evaluating the effect 
on the investigated system in the presence of caging group alone with/without light is 
one way to rule out such interfering processes. (2) Caged compounds are invariably 
larger than the released active compound. This poses a potential challenge for whole-
cell and/or organism studies where biological barriers typically need to be traversed, as 
(diffusional) uptake typically is size-dependent. (3) For potent effectors (for instance 
inhibitors in the pM – nM regime), small amounts of residual active compound from 
the synthesis (Figure 14a, the “Caging” step) may be sufficient to cause a significant 
effect in the absence of light. This imposes high demands regarding purity.12 (4) The 
caged compound needs to be stable toward solvent-induced- and enzymatic decaging. 
Potential decaging enzymes include e.g. esterases. 
4.3 Supramolecular Approaches for Extending 
Photochromic Properties 
The preceding sections 4.1 and 4.2 describe how clever design of photoswitches and 
cages has resulted in a range of photocontrolled compounds and applications for use 
in biology. With these strategies, however, the attainable biological effects are restricted 
to those inducible by the isomeric forms of the photoswitch or the decaging products. 
A convenient way of extending the effects of a photoswitchable system beyond the 
properties of the available isomers is by introducing additional (not necessarily 
photoresponsive) components, with which the photoswitch can interact. Such 
interactions can either be facilitated by linking the two units covalently (typically 
requiring extensive synthetic efforts), or by designing self-assembled supramolecular 
systems, as focused on below.136 
In principle, if a compound has a certain activity in the presence of one isomeric 
form of a photoswitch, and a different activity in presence of the other, the 
photoswitching ability can be regarded as transferred to the non-photochromic unit. A 
biorelevant implementation of this concept was recently shown by the group of 
Feringa, where a metal-coordinating DTE photoswitch was used together with a 
Zn-porphyrin.137 In solution, the DTE-unit and Zn-porphyrin self-assembled to form 
a supramolecular complex. As a result of differences in energies between the DTE 
isomers, excited state quenching of the Zn-porphyrin (with concomitant loss of 
sensitizing ability) could be reversibly controlled by photoswitching the DTE-unit. 
This example shows how properties not associated with the photoswitch (here: 
generation of singlet oxygen) can be photocontrolled. Another very recent report on 
this strategy was presented in the work by Presa et al., in which the cancer cell 
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cytotoxicity of Pt-based compounds were brought under photonic control; again using 
a metal-coordinating DTE.138 The change in toxicity was proposed to be due to 
differences in DNA-binding affinities between the open and closed form of the DTE, 
when bound to the Pt-complexes. 
An alternative approach for extending the effects of photoswitches is to use them 
as drug-displacement agents. By designing a supramolecular system where a drug of 
choice is encapsulated in a synthetic “host molecule”, release of the drug can be 
reversibly controlled if the photoswitch fulfills certain host-binding criteria. 
Specifically, a significant difference in host-binding affinity between the two isomeric 
forms of the photoswitch is required. Thus, in a typical drug release application, the 
weakly binding form of the photoswitch is distributed together with the encapsulated 
drug. Upon photoswitching to the high affinity isomer, the drug is displaced from the 
host due to competitive binding, and free to induce its intended effect. The advantage 
with this approach is that photoactivation can be accomplished without the drug itself 
having to be photoresponsive. 
Several studies on photoreversible complex-formations that could potentially be 
used in this manner have been reported, such as the photoreversible binding involving 
the macrocyclic hosts cucurbiturils139,140 and cyclodextrins.141,142 An interesting 
variation on this approach was published in 2013 by Han et al., where a 
photoswitchable “coordination-cage” composed of Pd-coordinated DTE-units was 
used to reversibly control the release of an inorganic guest in solution.143 In that work, 
the host molecule itself was photoswitchable, and able to reversibly displace its content 
in response to light as a result of changes in the size of the inclusion cavity. 
In this thesis, photoswitchable displacement strategies for photocontrolled drug 
release were studied in Papers II and IV. 
4.4 Targeting Kinases  
Protein kinases are defined by their ability to catalyze the transfer of a phosphate group 
from ATP (or GTP) to a serine, threonine, tyrosine, or histidine residue of another 
protein – the substrate. The reverse process is catalyzed by protein phosphatases; the 
two processes are shown in Figure 16 below. 
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Figure 16. Enzyme-catalyzed substrate phosphorylation/dephosphorylation, showing the role 
of kinases for facilitating the transfer of phosphate groups. 
There are over 500 protein kinases encoded in the human genome and they are 
implicated in virtually all biochemical cascades in our body by mediating signals and/or 
regulating the activity of other enzymes. In mammalian cells, three distinct classes of 
kinases have been identified based on their substrate preference.144 They include; 
serine/threonine kinases (S/TKs), tyrosine kinases (TKs), and the dual function 
kinases (DFKs), which have the combined substrate affinity of the former two.145,146 
The catalytic domain of protein kinases is structurally well conserved and consists of 
12 subdomains arranged into a C-terminal (consisting mainly of ߙ-helices) and N-
terminal lobe (anti-parallel ߚ-sheets).147 A defining binding interaction for ATP occurs 
in the so called hinge region located between the two lobes, where the kinase backbone 
makes hydrogen bonds to N2 and 6N of the ATP adenine moiety, as shown in Figure 
17.147  
 
Figure 17. Schematic representation of the binding characteristics of ATP in the kinase catalytic 
domain. The alternating H-bond acceptor/donor pattern (green/red) making up the hinge 
region, along with the hydrophobic pocket (blue), are highlighted. 
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 Many kinases have been found to be intimately connected to processes leading to 
tumor cell proliferation and survival. As a result, oncology drug research has focused 
considerable attention to the development of kinase inhibitors for cancer treatment.148 
Kinase inhibitors are divided into four subcategories based on their binding 
interaction.148  
x Type I inhibitors are ATP competitive and bind to the active 
conformation of the kinase active site.  
x Type II inhibitors are also ATP competitive, but recognizes the inactive 
conformation of the kinase active site. 
x Type III inhibitors (or allosteric inhibitors) bind outside the ATP binding site 
and reduces kinase activity, often by changing the active site 
conformation. 
x Covalent inhibitors bind irreversibly to the kinase active site. 
The majority of kinase inhibitors are ATP competitive (Type I or Type II), and thus 
mimics the binding of ATP in the active site. Despite being a recognized biomedical 
target, examples of photocontrolled small-molecule kinase inhibitors are few. This is 
somewhat surprising, as emergence of photocontrolled analogs could be expected to 
correlate with general biomedical trends. The so far reported examples are caged 
variants.149,150 As for reversibly photocontrolled kinases, two examples of 
peptidomimetic approaches have been reported by the group of Liskamp.151,152 
Regarding photoswitchable small-molecule kinase inhibitors, Paper V shows the only 
existing example to date. 
4.4.1 Receptor Tyrosine Kinases and the RET Kinase 
The REarranged during Transfection kinases (RET) belong to the receptor tyrosine 
kinases (RTKs).††††153 The RTKs are single pass, transmembrane kinases with the overall 
function to transduce signals across the cell membrane; they are necessary for 
development, maturation and maintenance of a number of cell types in the human 
body. An RTK signaling event is initiated by the binding of growth-factor to an 
extracellular receptor-site of the kinase, causing dimerization of two kinase units in the 
cell membrane. The dimerization is then followed by autophosphorylation on tyrosine 
residues of the kinase, activating the kinase binding pocket on the intracellular side. 
Once activated, the kinase mediates downstream signaling pathways inside the cell, 
                                                          
†††† The name “Rearranged during Transfection” relates to the initial discovery of the gene coding for 
the RET kinase, which was found to rearrange upon transfection with DNA from human lymphoma cells.  
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leading to cell proliferation and/or differentiation.154 A conceptual schematic of RTK 
signal transduction is shown in Figure 18. 
 
Figure 18. A schematic of receptor tyrosine kinase (RTK) signal transduction. i) Growth factor 
(GF) binds to the extracellular receptor site of the RTK, stimulating dimerization of two 
membrane bound RTK-units. ii) Autophosphorylation (P) occurs (typically in multiple sites), 
activating the kinase binding domain on the intracellular side. iii-iv) Substrate (S) 
phosphorylation propagates the signal on the intracellular side, completing its membrane 
passage. 
In particular, RET has been shown to be important in the development and 
maintenance of neurons of the central and peripheral nervous systems.155 If the normal 
function of RET is compromised, for instance by point-mutations leading to 
constitutive activity and/or overexpression of the kinase, uncontrolled (tumorous) cell 
growth may result. Accordingly, dysregulation of RET has been intimately connected 
to several types of human cancers, most notably in the thyroid gland and 
kidney.146,155,156 In addition, the recent discovery that RET is important in breast cancer 
is likely a contributing factor to the increased interest in RET signaling, as breast cancer 
is the most common cancer form.157 For these reasons, RTKs in general and RET in 
particular have emerged as attractive therapeutic targets for small-molecule kinase 
inhibitors. 
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5 Original Work 
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The following chapter presents a commented condensation of the results from the 
papers on which this thesis is based. It is my intention that the “biological complexity” 
of the studied systems should increase throughout the three parts of this chapter; 
starting with basic spectroscopic studies of isolated photochromic systems in solution 
and ending with phototriggered inhibition in a live organism. 
5.1 Characterization and Supramolecular Interactions of 
Photoswitches in Solution 
This first section cover Papers II, III, and IV and describes how supramolecular 
complexes based on photoswitchable components can be used to tune photochromic 
properties and/or realize novel drug release systems. It also includes a kinetic study of 
the thermo- and acidochromic reactions of a series of spiropyran photoswitches in 
water, with particular emphasis on hydrolysis. 
5.1.1 Supramolecular Systems for Photocontrolled Drug Release 
Described in this section are two examples where a photoswitch was combined with a 
non-photochromic host molecule to realize photocontrolled drug release on the basis 
of competitive binding. In the first part, the supramolecular interactions between a 
pyridine-appended DTE photoswitch and a diethyne-linked porphyrin dimer were 
exploited to reversibly control the concentration of the neurotransmitter 
4-aminopyridine in toluene solution. The second part outlines a similar attempt, using 
an aminoalkyl functionalized (“anchor-equipped”) nitro-spiropyran together with a 
cucurbit[7]uril (CB7) macrocycle in water. However, due to the loss of bistability of 
the spiropyran in the presence of CB7, we were unable to realize the proposed release 
system. Instead, the complexation-induced thermo-, photo-, and acidochromic 
reactions, as well as hydrolytic properties of the spiropyran complex were 
characterized. The principles for the herein intended photocontrolled drug 
displacement systems are shown in Figure 19. 
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Figure 19. Photoswitchable supramolecular scaffolds for dynamic drug displacement. Based on 
the binding interactions of known static binders to macromolecular host molecules (framed), 
two potentially photoswitchable approaches were devised. a) The static bidentate binder 
presented by Winters et al.158 motivated the design of a pyridine appended DTE photoswitch. 
The increased structural flexibility of the ring-open DTE-isomer allows coordination to both 
Zn-center in the porphyrin dimer, with increased binding affinity compared to the singly 
coordinating closed form. Here, R = 3,5-di(tert-butyl)phenyl, Ar = Si(C6H13)3. b) The strong 
binding interactions between CB7 and protonated cadaverine (1-5-diaminopentane, K1:1 = 
1.4 ൈ 107),159 inspired the design of an aminoalkyl-linked spiropyran. The cadaverine-like motif 
(both nitrogens positively charged) is only present in the open merocyanine form. It was 
hypothesized that this isomer would bind stronger to CB7 than the corresponding spiro-form.  
The characterization of the two systems are described separately in the following 
sections 5.1.2 and 5.1.3, starting with the porphyrin-DTE scaffold. 
5.1.2 Porphyrin Coordination – Drug Release with a Twist  
In 2007, Winters et al. published a study showing how the rate of electron transfer from 
a porphyrin dimer to a covalently linked C60 electron acceptor could be controlled by 
selectively exciting different rotamers of the dimer.158 In that study, a static 
pyridine-appended bidentate ligand was used to bind to the two Zn-centers of the 
dimer, thereby forcing a coplanar arrangement of the porphyrin macrocycles (Figure 
19a, framed). The changes in the absorption spectrum accompanying the planarization 
(discussed in section 5.1.2.2 below) were later exploited in a photoswitchable system 
by Kärnbratt et al. to realize a light-operated logic memory device with non-destructive 
readout capabilities.160 Based on the latter system, we turned to investigate the 
possibility to use the same scaffold to reversibly control compound concentration in 
toluene solution, as outlined in Figure 19a above. 
To assess the potential for the photoswitch to exert control over guest concentration, 
it is imperative to establish the binding stoichiometry and affinities of the isomeric 
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forms of the DTE derivative in the presence of the porphyrin dimer P2 (see Figure 20 
below for structures). To this effect, UV/vis absorption titrations were carried out. 
The structures and fitted binding constants of the involved compounds are shown in 
Figure 20. 
 
Figure 20. Structures and binding constants (K11; K12, to P2 in toluene) of the compounds 
included in the porphyrin release scaffold. Here, R = 3,5-di(tert-butyl)phenyl, Ar = Si(C6H13)3. 
All guests bind to P2 in a consecutive 1:2 (H:G) manner except DTEo, which formed 1:1 
complexes. The guest molecules 4-aminopyridine (G) and perylene-appended G-Pe were used 
as model drugs for demonstrating the release event (see text below). 
The titrations reveal formation of consecutive 1:2 complexes (H:G) for all guests 
except DTEo, which instead forms a 1:1 complex. As for binding strength, the DTEo 
binds significantly stronger to P2, due to the conformational flexibility, which allows it 
to stretch and coordinate to both Zn-centers. 
5.1.2.1 Photoreversible Release  
To demonstrate the release event, a fluorescent model drug (G-Pe) was synthesized, 
as an analog to the bio-relevant neurotransmitter 4-aminopyridine (G).161 When 
coordinated to P2, the spectral overlap of the P2 absorption and G-Pe emission assures 
effective quenching of G-Pe emission via FRET (ܴ଴ = 66 Å). Therefore, any observed 
emission originates from the released compound. Predicting the equilibrium 
concentrations as a function of binding constants and/or total concentrations requires 
solving a set of coupled mass-balances and equilibrium conditions (see the earlier 
section 2.5). Based on the results from such an exercise, we prepared a cocktail of 
280 μM P2, 300 μM DTE and 1 μM G-Pe to illustrate the photoreversible guest 
release. The results are shown in Figure 21.  
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Figure 21. Photoreversible release of G-Pe. The applied concentrations were [P2] = 280 μM, 
[DTE] = 300 μM, [G-Pe] = 1 μM. Initially, the photoswitch was in the open form, DTEo (solid 
black line). UV exposure for 2 min (302 nm) triggers isomerization to DTEc (dash-dotted black 
line). Subsequent visible-light irradiation isomerizes the sample back to DTEo (λ > 550 nm, 3 
min, dashed red line). 
An initial solution containing P2, DTEo, and G-Pe gives rise to high emission, as the 
strongly coordinating DTEo occupies both Zn binding-sites in P2. Subjecting the 
solution to UV light causes DTEo → DTEc isomerization, whereafter each DTE-
unit cannot coordinate more than one Zn-center. In response, G-Pe binds to the 
liberated coordination site, and the emission is quenched. Subsequent visible light 
restores the high emission by reforming DTEo and displacement of G-Pe from P2. 
This effectively illustrates the ability of the scaffold to reversibly release the guest into 
solution, using only light stimuli. 
5.1.2.2 Report Function  
The absorption spectrum of P2 changes significantly upon guest coordination (Figure 
22a). In particular, ligand-induced P2 planarization (here, via coordination to DTEo) 
causes a substantial increase and red-shift of the 600 nm – 750 nm absorption band of 
P2 (Figure 22a, black → solid blue line). This was used in the present study to monitor 
the state of the release scaffold. Since detection of the planarized complex signals “drug 
released”, we probed the inherent P2 emission (Figure 22a, dashed blue line) by exciting 
the mixture at 790 nm, where P2 is the sole chromophore. 
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a) b)  
Figure 22. Report function of the P2 release scaffold. a) Absorption spectra of the 
supramolecular P2-complexes in toluene: P2 (black line), 2G@P2 (red line), and the planarized 
DTEo@P2 (blue line). The dashed blue line shows the DTEo@P2 emission spectra 
(ߣ௘௫௖  = 510 nm). Inset: Absorption from 380–825 nm. b) Photoswitching performance, as 
monitored via the report function, i.e. emission intensity at 800 nm (ߣ௘௫௖ = 790 nm). Applied 
concentrations: [P2] = 280 μM, [DTE] = 300 μM, [G] = 1 μM. Each cycle starts with the 
photoswitch in the open form, DTEo, (high intensity). UV exposure triggers isomerization to 
DTEc (low intensity). Subsequent visible light isomerizes the sample back to DTEo. 
This shows that the release event can be confirmed by fluorescence means, as the drug 
release proceeds concurrently with a dramatic increase in P2 emission, in accordance 
with the absorption spectral shift of P2 (Figure 22a, red → blue line). Therefore, the 
presented release scaffold fulfills the criteria for an all-photonic release-and-report 
system.  
5.1.3 Spiropyran Complexed to CB7 – Altered Stabilities 
The barrel-like host molecules cucurbit[n]urils, and in particular the water soluble 
homolog CB7 (Figure 23), have attracted considerable attention the last twenty years, 
mainly due to advancements in the synthesis of this class of compounds.31 Its 
documented usefulness as a delivery vehicle162,163 in combination with low cell 
toxicity164 has seen it included for instance in a supramolecular approach for staining 
RNA in live cells.165 Preferred guests for CB7 inclusion are organic species with two 
suitably spaced (the depth of CB7 is 9.1 Å) cationic ends. This is due to the combined 
interactions with the two carbonyl rims and hydrophobic interior of the macrocycle 
(Figure 23a).  
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Figure 23. a) Structures of CB7 and protonated cadaverine (1,5-diaminopentane). The dashed 
arrows indicate attractive forces between the two molecules.159 b) Structures and isomerization 
scheme of 1, highlighting the structural resemblance of the aminoalkyl tail to cadaverine. 
To determine the potential of 1 to function as a phototriggered drug displacement 
agent (as conceptually outlined in Figure 19b), the binding of the isomeric forms of the 
spiropyran to CB7 were investigated. Upon addition of CB7 to a water solution 
containing the closed SP-form, however, a dramatic acceleration of the thermal 
SP → MC isomerization was observed. The apparent rate of ring-opening was 
increased 70-fold, as shown in Figure 24. 
 
Figure 24. UV/vis time-trace monitoring the MC-form (ߣ௢௕௦ = 501 nm) as a function of time 
in the dark. At the start of the experiment, 1 (10 μM) was in 100% SP-form. The thermal opening 
was then monitored in the absence (solid line) and presence (dashed line) of 200 μM CB7. 
This unexpected loss of bistability seriously limited the potential of the 1-CB7 system 
as a photocontrolled drug release scaffold, as any distributed SP-isomer would be 
converted to the corresponding MC-form on the minute timescale, even in the absence 
of light. In addition to the rapid isomerization, several other physicochemical 
parameters of the photoswitch changed as a result of CB7 complexation. Of particular 
note, the hydrolytic degradation, commonly observed on the hour timescale for 
spiropyrans was completely halted in the presence of CB7.  
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5.1.3.1 Anchor-directed CB7 complexation 
In parallel to our research on the 1-CB7 system, reports from the group of Biczók 
emerged, describing spiropyran inclusion effects in CB8166 and CB7167. In their work 
with the CB7 homolog, the complexation to a spiropyran without an amino anchor 
group (Figure 25a) was studied. There, no binding of the MC-form and thus no change 
in hydrolytic behavior (hydrolysis targets the MC-isomer only) was reported. To 
illustrate the necessity of equipping the spiropyran with an “anchor-group” for 
obtaining the herein described effects, we performed kinetic experiments with a small 
series of spiropyrans having different anchor lengths. The results are shown in Figure 
25.  
a) 
b)  
Figure 25. a) Structures of the spiropyrans included in the CB7 kinetics study. b) UV/vis 
time-trace monitoring the MC-form at the respective ୫ୟ୶ as a function of time in the dark. At 
the start of the experiment, the compounds (10 μM) were in 100% SP-form. The thermal 
opening was then monitored in the absence (solid line) and presence (dashed line) of 200 μM 
CB7. 
This clearly shows that both the accelerated SP → MC isomerization and the hydrolytic 
stability is significantly more pronounced for the “full-anchor” equipped spiropyran. 
Regarding the CB7 binding mode and -strength, UV/vis absorption titrations with 
1-MC and 1-MCH+ revealed the formation of an initial 1:1 complex followed by a 
significantly weaker binding of a second CB7.‡‡‡‡ Supported by NMR and ESI-MS 
experiments, we attributed the initial strong complex formation to anchor immersion 
                                                          
‡‡‡‡  The binding constants of 1-MC and 1-MCH+ to CB7 were K1:1 = 1.2 ൈ  105 M-1; 
K1:2 = 1.3 ൈ 103 M-1 and K1:1 = 7.9 ൈ 105 M-1; K1:2 = 8.6 ൈ 103 M-1, respectively. Assessment of 1-SP binding 
characteristics were complicated by the rapid thermal ring-opening and overlapping absorption from CB7. 
Titration experiments under constant visible-light irradiation (continuously reconverting MC to SP) showed 
spectral similarities to the open form titrations. However, no binding constants could be extracted. 
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into the macrocycle, while the weaker binding was thought to be an exo-complex, where 
the CB7 binds to the indole ring-system of the photoswitch.  
With this binding arrangement, the CB7-induced acceleration of the ring-opening 
was explained by a stabilizing interaction occurring between the partial negative charge 
on the CB7 carbonyls, and the positive charge on the indolenium nitrogen of 1-MC, 
which likely is formed in an intermediate step in the course of SP → MC isomerization. 
This is further supported by the CB7-induced lowering of the apparent activation 
energy for the reaction (ܧ௔ = 109 kJ/mol → 88 kJ/mol). The cessation of hydrolysis 
is proposed to be due to electrostatic repulsion between the water molecules (see 
section 5.1.4 on hydrolysis of spiropyrans) and the carbonyl oxygens of the CB7 rim. 
Importantly, and in contrast to what has been reported for spiropyran immersion in 
CB8,166 the photoswitching behavior of 1 was not compromised upon binding to CB7. 
This highlights the usefulness of the anchor approach, as it retains the photoswitching 
properties of the spiropyran when bound to the CB7 host.  
5.1.4 Spiropyrans in Aqueous Solution – a Kinetic Study 
This section provides a brief account on the thermal and hydrolytic processes of 
spiropyrans in aqueous solution, as studied in Paper III. Since the first description of 
the hydrolysis of spiropyrans in the communication by Stafforst and Hilvert from 
2009,64 little has been done to systematically scrutinize on the behavior of this 
photoswitch in water. In Paper III, we proposed a complete kinetic model that 
accounts for the thermal interconversions of the spiropyran photoswitch over a broad 
pH interval in water. The model was validated using kinetic experimental data for a 
series of six spiropyrans designed to bestow the spiropyrans with varying acidities (vide 
infra). The proposed kinetic scheme along with the structures of the compounds 
included in this study are shown in Figure 26. 
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Figure 26. a) The proposed kinetic scheme of the thermal processes of spiropyrans in aqueous 
solution. Here, the interconversions between the spiro- (SP), and merocyanine (MC) isomers, 
their respective protonated forms (SPH+ and MCH+), and the hydrolysis products (HP) are 
shown. For the representative molecular structures, see section 4.1.1, Figure 9. The rate 
constants for the opening- (݇௢), closing- (݇௖), hydrolysis-, (݇௛) and condensation reaction (݇ି௛), 
as well as protonation constants (݌ܭ௔ூ  and ݌ܭ௔ூூ ) are indicated. The condensation reaction 
(“reverse hydrolysis”) is motivated in the text below. b) Structures of the spiropyrans included 
in Paper III. 
5.1.4.1 Protonation Constants 
The first step in this characterization study was to determine in detail the influence of 
substituents on ݌ܭ௔ூ  and݌ܭ௔ூூ. Due to the distinct spectral differences of SP vs. SPH+ 
and MC vs.MCH+ (section 4.1.1, Figure 10), this information could be readily extracted 
from UV/vis -titrations. The collected acidity constants of 1-6 are shown in Table 
1. 
Table 1. ୟ-values of SPH+ (݌ܭ௔ூ ) and MCH+ (݌ܭ௔ூூ) for 1-6. 
Compound 1 2 3 4 5 6 
݌ܭ௔ூ  1.4 1.6 0.4 0.4 0.4 0.4 
݌ܭ௔ூூ 4.2 4.4 4.2 3.7 4.4 4.5 
From these results, it was concluded that the length of the aminoalkyl tail in the 
R1-position significantly affected݌ܭ௔ூ , while it had no effect on݌ܭ௔ூூ. The lower݌ܭ௔ூ   
observed for the amino-functionalized spiropyrans with a three-carbon tail compared 
to five-carbon tail was attributed to the proximity of the cationic nitrogen to the 
protonation site, leading to more effective electrostatic proton repulsion. This is an 
important finding, since the protonated spiro-form (SPH+) is non-photochromic.70 
Thus, lowering ݌ܭ௔ூ  effectively extends the functional -range of the photoswitch. It 
should be noted that the corresponding ݌ܭ௔ூ-value for spiropyrans with a methyl in the 
R1-position is significantly higher (ca. 2.3).§§§§ As for substituents in the R2-position, it 
was seen that substituting the strongly electron-withdrawing nitro-group for the 
                                                          
§§§§ Unpublished results. 
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moderately deactivating cyano-group or aldehyde, causes an increase in ݌ܭ௔ூூ of ca. 0.8 
-units. Also, the applied R2-substitutions did not alter݌ܭ௔ூ , which indicates that the 
two acidity constants can be controlled independent of each other. 
5.1.4.2 Thermal Kinetics 
The ୟ-values (Table 1) show that for  6-10, very little protonated form is present 
in solution. Therefore, in this -range, the equilibria shown in reaction [38] prevails. 
 ܵܲ
݇௢
֖
݇௖
ܯܥ
݇௛
֖
݇ି௛
ܪܲ [38] 
To investigate how these rate constants varied with  for the different compounds, 
we initiated a kinetic investigation where the rate of formation and subsequent 
degradation of the MC-isomer***** was monitored using UV/vis spectroscopy. Under 
these circumstances, the SP-form is thermally isomerized to the MC-form whereafter 
the MC-isomer reacts to form the respective hydrolysis products. Kinetically, this 
renders a bi-exponential “rise-and-decay” profile (Figure 27) from which two apparent 
rate constants can be extracted. 
 
 
Figure 27. UV/vis absorption time-trace of the thermal SP → MC isomerization, and 
subsequent hydrolysis at 25 ºC, pH 7 (black line, the red line shows the bi-exponential fit), here 
exemplified for 4. At t = 0, the spiropyran is 100% in the SP-form. Inset: absorption spectrum 
recorded at t = 12000 min, clearly showing the presence of MC-form at equilibrium. 
As the kinetic curve leveled off at a non-zero value, it is clear that the hydrolysis is 
reversible (Figure 27). This motivates the inclusion of the reverse hydrolysis reaction 
in the kinetic scheme. From the rate expressions for [SP], [MC] and [HP] and the two 
                                                          
***** The corresponding kinetic investigation at lower  instead monitored the MCH+-form. 
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fitted apparent rate constants (Figure 27, red line), the intrinsic rate constants  depicted 
in reaction [38] can be extracted analytically using a Laplace transform method.168 To 
give a representative example; the kinetic experiment of 4 (Figure 27), renders intrinsic 
rate constants [min-1]; ݇௢  = 3.5ൈ10-3, ݇௖  = 5.1ൈ10-3, ݇௛  = 2.2ൈ10-3, and ݇ି௛  = 
9.8ൈ10-5. The corresponding experiment was made for compounds 4-6 at  6, 7, 8, 
9, and 10. †††††  The results showed that ݇௢  and ݇௖ , although varying between the 
compounds, remained constant over the -range 6-9. Also, ݇௛ was the same for all 
investigated compounds and did not change with. The concentration of hydroxide 
ions changes 1000-fold over this -range, while the observed rate of hydrolysis 
remains virtually constant. This strongly suggests that water (rather than the hydroxide 
ion) is the main nucleophile in this regime. This notion was further supported by 
computational means. 
The same methodology as described for  6-9 above was applied to determine 
the rate constants also at  0-1, where the kinetic scheme can be reduced to include 
only SP, SPH+ and MCH+. It was seen that the extracted rate constants݇௢ and݇௖ 
agreed very well to those determined for  6-9. Thus, the near-identical ݇௢ and݇௖ 
from  0 to 10 strongly suggests that no direct acid-induced SP → MCH+ reaction 
takes place, but rather that MCH+ is formed by SP → MC isomerization followed by 
immediate protonation of MC.  
Finally, the intermediate -range 2-4, where the full kinetic model must be 
applied, was investigated. We were unable to find an analytical solution to the full 
kinetic scheme, why a numerical assessment was performed instead. It was seen that 
combining the intrinsic rate constants extracted for   5 with the determined 
ୟ -values (Table 1), resulted in a kinetic trace that agreed very well with the 
experimental results, thus verifying the proposed kinetic model also in a -range 
where the full model is required.  
In summary; the kinetic investigation shows that one set of intrinsic rate constants 
can be applied to describe the thermal kinetics of a spiropyran in aqueous solution over 
a wide -range ( 0-9), according to the proposed kinetic scheme (Figure 26a). 
Furthermore, the differences in the apparent rate of hydrolysis between the spiropyrans 
is not due to different inherent hydrolytic rate constants (݇௛). Rather, it is determined 
by the protonation constants (Table 1) and differences in the rate constants of ring-
opening and closing (݇௢ and݇௖, respectively), which in turn governs the concentration 
of the hydrolysable MC-isomer in solution. 
 
                                                          
††††† The complete set of extracted rate constants are summarized in the SI of the appended Paper III. 
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5.1.5 Discussion and Conclusions 
The research summarized in section 5.1 focuses on basic molecular interactions in 
solution. Compared to the results described later in the present chapter, this research 
is of more fundamental character. It is therefore worth reiterating that the above 
described principles, e.g. for how a drug release strategy can be developed, requires 
several steps of refinements before they may be applicable in a biological setting. 
Regarding the P2-DTE drug release study, it is concluded that the concentration 
of drug in solution can be effectively controlled by photoswitching the DTE unit in 
the presence of P2. Also, the spectral changes inherent to the release scaffold allow for 
fluorescence-based readout to determine the status (i.e. bound or unbound) of the drug. 
This combined all-photonic ability to reversibly release drugs and simultaneously 
report back to the user, could be of tremendous use for triggering and monitoring drug 
release e.g. in a microscopy setup. A particularly attractive feature with the presented 
system is that both the release- and report function can be triggered with low energy 
photons (up to ca. 700 nm), in compliance with operation in the therapeutic optical 
window. 
Three limitations in the P2-DTE system are obvious. First, for solubility reasons, 
the study was performed in toluene. It should be noted, however,  that water-soluble 
versions of a similar porphyrin dimer169 and DTE photoswitch113 have been presented 
and used in biological matrices. It is acknowledged that other solvents (such as water) 
likely would affect the affinities of guests to P2, and therefore the performance of the 
release scaffold. Second, the ratio bound/unbound drug upon photoswitching is ca. 
two-fold. It is debatable if this change in guest concentration is sufficient to induce a 
significant response in a biological system. Third, the required concentrations of the 
scaffold-components, [DTE] [P2], are substantial compared to [G], (ca. 300 μM vs. 
1 μM). Such high operating concentrations raise general concerns regarding for 
instance solubility and/or toxicity toward the exposed matrix.  
As for the second pursued system for drug release, involving the CB7-spiropyran 
couple, the loss of bistability of the photoswitchable system coincided with the 
serendipitous discovery of the CB7-induced stabilization toward hydrolysis of the 
spiropyran unit. The ensuing characterization study allowed for the following 
conclusions to be drawn. (1) The hydrolytic degradation of spiropyran 1 is completely 
halted when bound to CB7. (2) The 1-SP → 1-MC isomerization is accelerated by a 
factor of 70 with (compared to without) CB7 present. (3) The spiropyran binds to CB7 
by immersion of the cadaverine-derived anchor substituent. (4) The anchor binding-
mode is necessary for obtaining the observed complexation effects, whilst maintaining 
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unhindered photoswitching capabilities. The benefit of stabilizing the photochromic 
system toward hydrolysis is obvious. Also, as briefly discussed in section 4.1, a 
spontaneously reverting photochromic system may for some applications be 
advantageous, or even necessary. However, further studies are needed to clarify the 
physicochemical characteristics attributed to photoswitching of the CB7-spiropyran 
complex, to aid the design of novel applications based on this system. 
In the third presented study, on spiropyran hydrolysis, a comprehensive kinetic 
scheme for the thermal reactions of spiropyrans in aqueous solution was proposed and 
validated. This general kinetic framework is expected to provide useful guidelines when 
designing spiropyrans for biological use. The results should be of interest e.g. when 
selecting substitution pattern for applications where the relative concentrations of the 
spiropyran isomers (and in particular their respective protonated forms) are important. 
5.2 Live-cell Study of Spiropyran Cytotoxicity  
This section describes how the cytotoxicity of a photochromic spiropyran can be 
regulated by light. The results and discussion in this section are largely based on the 
work contained in Paper I. 
5.2.1 Motivation – Photoswitchable DNA-binding 
There are few reported examples of photoreversibly controlled biological processes 
where the effects can be observed on a whole-cell or organism level. An important 
contribution emerged in 2009 when Branda and co-workers demonstrated the use of 
a DTE photoswitch for reversible control of paralysis in C. Elegans nematodes.120 
Azobenzenes have also been used in similar studies, for instance to photocontrol the 
motility of Xenopus tropicalis tadpoles via an allosteric modulator of metabotropic 
glutamate receptor, mGlu5.101 Another noteworthy example using an azobenzene is the 
photoswitchable propofol analog developed by the Trauner group, which was used to 
reversibly trigger anesthesia in Xenopus laevis tadpoles.102 
Small-molecule DNA-binders hold great promise for disrupting DNA-dependent 
cellular processes and thereby inducing toxic effects in cells. Given that selectivity 
toward unhealthy cells can somehow be achieved, this type of compounds could be 
used to target for instance fast replicating cancer cells. In the work by Andersson et al. 
from 2008, photoswitchable DNA-binding was demonstrated.73 More specifically, a 
photochromic spiropyran (Figure 28, 4) was proposed to bind significantly stronger to 
DNA when in the open isomeric form, compared to the corresponding closed spiro-
form. Later, in 2010, Hammarson et al. used a similar spiropyran derivative to 
demonstrate that the DNA-binding in fact depends on the protonation state of the 
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open isomer (MC/MCH+, see section 4.1.1), and that efficient DNA-binding occurs 
only after protonation of the phenolate oxygen on the MC-isomer.71 This was 
suggested to allow for a dual control mechanism for DNA-binding, as both an external 
trigger (light) and an internal acidity control (cancer cells typically exhibit lower pH 
than healthy cells170) would be required. Apart from the herein appended Paper I, the 
only spiropyran toxicity study published to date is that of Movia et al. 171 where an 8-
methoxy-6-nitro BIPS (Figure 28, 1) spiropyran was shown to be non-toxic for up to 
72 h in the low micromolar concentration regime. In that study, however, no attempts 
were made to investigate the effects of photoswitching in the cells. Based on the 
research presented above, we turned to investigate the cellular effects of 
photoswitching the spiropyran to the DNA-binding open form inside live human 
cancer cells, in an attempt to realize selectively triggered cell-death. 
 
Figure 28. Structures of previously studied spiropyrans 1 and 4 and isomerization scheme of 3. 
5.2.2 Physicochemical Properties 
Early attempts suggested that 4 was not appreciably taken up by the human embryonic 
kidney (HEK293T) cell-line, possibly due to the permanent charge on the quaternary 
aminoalkyl functionality. ‡‡‡‡‡  Therefore, we instead turned our attention to the 
structurally very similar 3 (Figure 28), differing only by carrying a tertiary amine instead 
of quaternary amine on the indoline tail group. 3-SP can be photoswitched to the 
colored 3-MC (see Figure 29 for spectra) using 254 nm UV light, and the PSD reached 
is ca. 40/60 3-SP/3-MC. Visible light stimulates the reverse reaction, and converts the 
sample to virtually 100% SP-form. Left in the dark, a 50/50 thermal equilibrium 
isomeric distribution is established with a time constant of ca. 6 h. Spiropyran 
hydrolysis is also observed, although on a significantly longer timescale (time-constant 
                                                          
‡‡‡‡‡ Unpublished results 
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ca. 50 h). An important characteristic of 3 in terms of imaging is the fluorescent 
properties of the MC-form (ߔ௙  = 0.01), which is the only emissive isomer. This 
allowed for localization of 3-MC by means of fluorescence microscopy. 
 
 
Figure 29. UV/vis absorption spectra of 3-SP (black), 3-MC (red) in water. The emission 
spectra of 3-MC is shown in dashed blue. 
5.2.3 Cell Uptake and Localization 
DNA is primarily located in the nuclei of cells.§§§§§ To be effective as a DNA-binding 
cytotoxic agent it is therefore necessary to be able to penetrate not only the cellular 
membrane but also the nuclear envelope. To assess the uptake ability of 3, a solution 
at thermal equilibrium (50/50 isomeric ratio) was distributed to HEK293T cells and 
incubated for 15 min at 37 ºC. The sample was then mounted on a confocal 
microscope stage and probed for 3-MC emission using 488 nm laser excitation. As 
shown in Figure 30a, little or no fluorescence was observed from inside the cells at this 
point, indicating the absence of internalized 3-MC. After exposing the entire field of 
view to 3 s UV light, the sample was again probed for 3-MC emission, resulting in 
intense fluorescence from inside the cells (Figure 30b). 
  
                                                          
§§§§§ There is also DNA in the cytoplasmic mitochondria organelle.  
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Figure 30. Confocal microscopy images (ߣ௘௫௖= 488 nm) of HEK293T cells incubated for 
15 min with 3 (6 μM) at thermal equilibrium, i.e. at 50/50 isomeric ratio a) before and b) 
immediately after exposing the entire field of view to 10 s UV light. The UV light was filtered 
out from the microscope mercury lamp (300 nm < ߣ < 400 nm). Scale bar is 30 μm. 
This shows that 3-SP is the only isomer able to pass the cell membrane and that 
intracellular SP → MC isomerization can be triggered photonically. Judging from the 
charge distribution of the respective isomers (the MC-form is zwitterionic and 
significantly more polar than the SP-form), the discrimination in uptake is not 
surprising, as increased size and polarity generally has a negative effect on cell uptake. 
Also, a similar uptake pattern was observed for the corresponding incubation at 4 ºC, 
suggesting mainly a passive diffusion rather than endocytotic uptake mechanism. As 
for intracellular localization, it is clear from Figure 30 that fluorescence intensity from 
the cell nuclei is low. This suggests that neither form of 3 is able to effectively penetrate 
the nuclear envelope (or is efficiently quenched) under the applied conditions. Some 
binding preference seems to exist, however, as evidenced by the punctuate staining of 
the cytosol. 
5.2.4 Cytotoxic Response 
Having confirmed uptake of the photoswitch, the next step was to investigate the 
cellular effect of photoswitching 3-SP → 3-MC inside the cells. As discussed 
throughout this thesis, phototriggered applications are often motivated by the superior 
target selectivity that comes with the directability of light. To illustrate this principle in 
the present study a preparation identical to that of the uptake study was followed by 
UV light-exposure of parts of the cell population (marked by circles in Figure 31). The 
response to the applied light dose was monitored by collecting microscope images with 
one minute interval. Selected images are shown in Figure 31 and the progression is 
described as follows; Immediately after the UV light-dose, the exposed 3-incubated 
cells detached from the glass surface, ‘‘rounded up’’, and commenced extensive 
membrane blebbing, (Figure 31b). This was followed by a phase where the effected 
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cells ceased to bleb and re-assumed a spherical shape. Finally, ca. 2 h after UV exposure, 
the cell membrane of the effected cells (Figure 31c, red arrows) burst.******  
 
Figure 31. Confocal microscopy images (ߣ௘௫௖  = 488 nm) of HEK293T cells incubated for 
15 min with 3 (6 μM) at thermal equilibrium, i.e. at 50/50 isomeric ratio. After incubation, 10 s 
UV-light (300 nm < ߣ < 400 nm) was applied exclusively to the circled region, where after an 
image time-lapse, collecting images every 60 s, was initiated. The displayed images are a) just 
before UV light-exposure, b) 29 min post UV, and c) 118 min post UV. The arrows show the 
cells initially hit by light, red arrows indicate ruptured cells. Scale bar is 30 μm. 
Importantly, neither UV light alone, nor extended incubation with the spiropyran in 
the absence of light caused comparable effects, indicating the necessity of both 
photoswitch and light for the cytotoxic effect to occur. The effect was also investigated 
on larger populations of cells, showing a 52 ± 9 % vs. 3 ± 2 % incidence of membrane 
blebbing for incubated and non-incubated cells, respectively. As for the features of the 
cellular response, the morphological changes exhibited by the effected cells strongly 
resembles the stages described as being trademark signs of apoptosis.172 This suggests 
that a cytosolic apoptotic pathway may have been triggered upon photoswitching. 
Inducing apoptosis, being a controlled dismantling of the cell, is typically preferred to 
the more traumatic necrotic cell death, as the latter is known to cause an inflammatory 
response in surrounding tissue and cells. 
5.2.5 Discussion and Conclusions 
It was concluded that an apoptotic-like cytotoxic response could be selectively 
phototriggered in spiropyran-incubated human cancer cells using light and drug doses 
that in themselves do not harm the cells. The specific cellular process intervened with 
to cause the observed cell-death is currently unknown. However, the uniformity in the 
morphological response of the irradiated cells suggest that the cells may commit to the 
same type of death-program. This may in turn indicate a specific disruptive binding of 
                                                          
****** For a compiled video capture of the entire cytotoxic event, see Supporting Information for 
Paper I, provided online by the RSC. 
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the MC-form in the cytosol. It should be noted, however, that nitro-substituted 
spiropyrans are known to isomerize on the triplet surface and thus are eligible 
candidates for generation of reactive oxygen species, why this possibility cannot be 
excluded.68 A notable strength with the applied spiropyran is the preferential uptake of 
the non-toxic SP-form, and the slow thermal isomerization to the MC-form in the 
cytosol, effectively holding back spontaneous buildup of the MC-isomer in the cell. 
5.3 Two Tools and Three Model Systems for Studying 
RET Inhibition 
This section is based on the work contained in Papers V and VI. Three model systems, 
i.e. studies on the isolated enzyme, live-cells, and zebrafish, have been used to 
characterize photoresponsive inhibitory activity against the RET kinase. Two strategies 
for gaining photocontrol of the inhibition event are presented; using a photoswitch 
and caged compound. They are described side by side in the ensuing text. 
5.3.1 Inhibitor Design 
In 2012, Grøtli and co-workers published a study on 3-substituted pyrazolopyrimidine 
kinase inhibitors for suppressing the activity of RET in an ATP-competitive manner.173 
Crystal structures of the RET kinase (PDB: 2IVV) with bound inhibitor I1 (Figure 32) 
inspired the design of a series of modified inhibitors aimed at improved 
inhibitor-kinase interactions by better utilizing the hydrophobic pocket in the ATP 
binding site (see section 4.4 for details on kinase binding sites).174 The best inhibitor, 
I2, showed potent RET inhibition in vitro (ܫܥହ଴ = 8 nM), and was shown to attenuate 
phosphorylation of ERK1/2, (a downstream reporter for RET activity) at nanomolar 
concentrations in MCF-7 breast cancer cells.173 
 
Figure 32. Structures of the nucleobase adenine and RET kinase inhibitors I1, and I2. 
ࡵ࡯૞૙-values toward RET (in vitro) are shown in parenthesis. 
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Based on the structure of I2, and the characteristics of the RET binding pocket, we 
investigated the possibility to photocontrol the inhibitory activity toward RET. To 
achieve this, two different approaches were pursued (Figure 33). First, a photoswitch 
methodology (Paper V) based on the introduction of an azo-bridge in place of the 
ethyne bridge of I2, rendering the azobenzene-derived compound I3, was examined. 
The hypothesis for discriminating binding between the two photoisomers (E-I3 and 
Z-I3) and RET was that the enzyme pocket would tolerate the E-conformation of I3 
but, upon photoswitching to the Z-conformation, a steric clash with the walls of the 
hydrophobic pocket would significantly hinder the binding, and lower the inhibitory 
potency.  
The second approach involved attachment of a carboxylic acid functionalized 
6-nitroveratroyloxycarbonyl (NVOC) caging group to the exocyclic nitrogen of I2, 
yielding the caged compound C1 (Paper VI). NVOC-caging has been shown by Neveu 
et al. to be effective both for one- and two-photon release of retinoic acid in live 
zebrafish, motivating the use of this caging group also in the present study.175 As for 
synthetic compliance, the NVOC-caging group has been used to cage purines in a 
similar fashion as in the herein reported C1.176 The carboxylic acid functionality on the 
C1 caging group was introduced to increase water solubility, as the corresponding 
methoxy compound was insufficiently soluble in water. Regarding the C1 binding 
mode in the RET active site, attachment of the caging group was anticipated to both 
prevent hinge-binding and introduce an overall severe steric bulk in the inhibitor.  
 
Figure 33. The two methods used for gaining photonic control over RET inhibitor activity. The 
line surrounding I2 is a simplified representation of the RET kinase binding pocket (see section 
4.4) depicting the hinge-region interactions (green and red ovals are H-bond acceptor and donor, 
respectively) and the hydrophobic pocket. a) Substituting the triple-bond of I2 for an azo-bridge, 
renders the photoswitchable compound I3. b) Attaching a photolabile group to the exocyclic 
nitrogen of I2 affords the caged compound C1.  
5.3.2 Physicochemical Characterization  
The ability of the photoresponsive compounds to control RET activity is very much 
dependent on the rates of the photoinduced and thermal reactions. The requirements 
and considerations for the two approaches (photoswitch vs. cage) in this respect are 
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notably different, as discussed in sections 4.1 and 4.2. First, the relevant photoinduced 
reactions (Figure 34) were studied in water.  
 
Figure 34. a) Photoswitching between the active (E-) and passive (Z-) inhibitor forms of I3. b) 
Liberation of active inhibitor I2 upon decaging of C1. 
Subjecting as-dissolved E-I3 to 365 nm light enriches the sample in the Z-isomer (see 
Figure 35a for spectra), and the PSD reached is ca. 87% Z-form. Photonic 
Z-I3 → E-I3 conversion can be stimulated with visible light. Here, 503 nm was used 
to complete the switching cycle, bringing the isomeric distribution back to >95% 
E-form. As for the C1 decaging kinetics, aliquots were drawn during irradiation and 
separated using HPLC. As expected, analysis of the C1 and I2 concentrations with 
respect to irradiation time revealed a first order decaging kinetics (Figure 35b). This 
clearly shows that C1 decaging (and thus liberation of the inhibitor I2) can be triggered 
with light. 
a) b) 
Figure 35. a) Photoswithing of I3. The as-dissolved E-I3 (solid line) was subjected to 3 min 
365 nm irradiation, yielding a PSD of 87/13 [Z-I3]/[E-I3] (dashed line). The inset shows the 
associated rates of photoswitching with time constants of 21 s (365 nm, 700 μW/cm2) and 37s 
(503 nm, 14 mW/cm2), for the E → Z and Z → E reaction, respectively. b) UV-induced 
decaging of C1 where the concentrations of C1 (solid circles) and I2 (hollow squares) are 
monitored (using HPLC) as a function of irradiation time. A global first order exponential fit 
including both traces showed a decaging time-constant of 9.6 min (365 nm, 700 μW/cm2). 
In addition to the photoreactions discussed above, thermal stability plays an important 
role in the performance of the photocontrolled inhibitors. As expected for azobenzene 
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photoswitches (section 4.1.2), the Z-isomer of I3 was shown to thermally revert to 
E-I3 with a time constant of 9.7 h at 37 ºC in the absence of light. This slowly cancels 
the effect induced by the initial photoreaction, as the inhibitor is spontaneously 
“reactivated” in the dark with time. Depending on the timescale of the intended 
experiment, this may limit the usefullness of I3 as an inhibitor. The cage C1, in contrast, 
was stable in aqueous solution. 
5.3.3 Studies on the Isolated RET Kinase 
Inhibitor studies on isolated enzymes in solution are gross simplifications of the 
situation in the corresponding native environment. However, because the inhibition is 
unperturbed by factors such as cell uptake, metabolism, and clearance, they offer the 
opportunity to study pure inhibitor-enzyme interactions with full control of enzyme-, 
substrate-, and co-factor concentrations. These systems are also free from ethical 
restrictions and typically more affordable than live-cell or in vivo assays. Thus, for 
establishing a biological effect of effectors, this type of study is often a preferred 
starting point. The RET tyrosine kinase domain has been isolated and adapted to an 
ATP → ADP conversion assay with luminescence readout, facilitating in vitro screening 
of RET kinase activity in the presence of effectors.177,178 The photoswitch I3 and cage 
C1 were screened for inhibitory activity using identical incubation procedures, apart 
from the applied light-doses (3 min and 15 min, respectively). The incubation was 
outlined as follows;  
i. The compound (i.e. I3 or C1) was included in two identical 
preparations with RET kinase, substrate, and co-factors.  
ii. One preparation was exposed to 365 nm light, while the other 
was kept in the dark.  
iii. ATP was added, followed by incubation at room temperature 
for 30 min. 
iv. The relative ATP turnover was assessed by addition of 
luciferase-based detection reagents.†††††† 
The resulting dose-response curves are shown in Figure 36 below.  
                                                          
†††††† For detection, several reagents were added in succession. First, the reaction was quenched, and 
the remaining ATP in the solution was depleted. Then, the ADP formed in the kinase reaction was converted 
to ATP. In the last step, a luciferease-based reagent was added to induce an [ATP]-dependent luminescence 
signal. Thus, the observed signal is directly proportional to the kinase activity. 
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a) b) 
Figure 36. In vitro inhibition studies on the isolated RET kinase. a) Incubation with E-I3, before 
(solid circles) and after (hollow squares) 3 min 365 nm irradiation. The dotted line represents the 
minimum inhibitory effect of I3, given the 87% Z-form PSD, and assuming no inhibitory effect 
of Z-I3 (see text below). b) Incubation with as-dissolved C1, before (gray triangles) and after 
(hollow squares) 15 min 365 nm irradiation. An identical reference incubation, albeit without 
light, including inhibitor I2 (solid circles) was also performed. An irradiation control of the RET 
kinase assay system showed no change in kinase activity by the applied light-doses. 
Photoswitching I3 from the thermally preferred E-form to the Z-form enriched PSD 
causes a significantly reduced inhibitory capability (ܫܥହ଴: 150 nM → 580 nM, Figure 
36a, dashed to solid line). Because the maximum light-attainable Z-content is 87% 
(meaning that at least 13% E-form is present), the maximum difference in inhibitory 
activity for this particular photoswitch (assuming zero inhibition from the Z-form) is a 
factor of 7.7. This limit is illustrated as a dotted line in Figure 36a. In general terms, for 
maximum modification of inhibitory effect upon photoswitching, the inhibitor should 
either exhibit quantitative (PSD = 100%), bistable photoswitching and/or be 
completely inactive in a thermally stable, isomerically pure form. Azobenzene-derived 
switches designed to be passive in the E-conformation are uncommon, but exceptions 
exist; one example is the photoswitchable antibiotic recently published by the group of 
Feringa.63 There is also the option of changing to a class of photoswitches with more 
favorable physicochemical properties. Photoswitchable enzyme inhibition has for 
instance been realized using the notoriously bistable DTE-type photoswitch.118,119,179  
As for the photocage, C1, Figure 36b shows that irradiation significantly increases 
the potency of the inhibitor as the ܫܥହ଴ shifts by a factor of 12, from ca. 6.8 μM to 
0.59 μM upon decaging. It can also be seen that the native inhibitor I2 exhibits a 
considerably more potent inhibition ( ܫܥହ଴= 72 nM) than irradiated C1. This is 
expected, as the decaging of C1 is not complete in the applied 15 min irradition (see 
decaging kinetics in Figure 35b). The partial inhibition exhibited by the non-irradiated 
caged compound C1 is somewhat surprising given its structural incompatibility with 
the RET binding pocket. Although C1 binding to the kinase active site cannot be 
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altogether excluded, a more likely explanation is the presence of small amounts of I2 
remaining from the synthesis of C1 (< 0.5% by HPLC). 
5.3.4 Kinase Inhibition in Live Cells 
Live cells studies are a significant step up in biological complexity compared to the 
corresponding experiments with the purified kinase. As a conceivable application for 
these photocontrolled tools is for RET signal transductions studies,4 it is required that 
they can be shown to be effective also in a living environment. The performance was 
evaluated in a live cell RET assay utilizing a β-galactosidase-based enzyme fragment 
complementation technique.180,181 As was the case in the incubation with the purified 
kinase, the live cell incubation procedure was identical for the photoswitch I3 and 
photocage C1, except for the applied irradiation times (3 min and 15 min, respectively). 
The incubation protocol was as follows;  
i. The compound was added to acclimatized live cells in two 
identical preparations, followed by preincubation for 3 h at 
37 °C.  
ii. One preparation was exposed to 365 nm light, while the other 
was kept in the dark.  
iii. The growth factor Neurturin was added, followed by 
incubation for 3 h at 22 ºC. 
iv. RET activity was assessed by addition of the supplemented 
detection reagents.  
The resulting dose-response curves are shown in Figure 37 below. 
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a) b) 
Figure 37. In vitro inhibition studies on live-cells expressing RET. a) Incubation with 
as-dissolved E-I3, before (solid circles) and after (hollow squares) 3 min 365 nm irradiation. The 
dotted line represents the minimum inhibitory effect of I3, given the 87% Z-form PSD, and 
assuming no inhibitory effect of Z-I3. b) Incubation with as-dissolved C1, before (gray triangles) 
and after (hollow squares) 15 min 365 nm irradiation. An identical reference incubation, albeit 
without light, including inhibitor I2 (solid circles) was also performed. An irradiation control of 
the live cells showed no change in RET activity by the applied light-doses. 
For the live cell incubation with the photoswitch I3, a 3.2-fold decrease in inhibitor 
potency is observed upon E-I3 → Z-I3 isomerization (dashed to solid line in Figure 
37a), which is consistent with the studies on the isolated kinase. In the incubation with 
the caged compound C1 (Figure 37b), we were unable to extract meaningful 
ܫܥହ଴-values with the data from the non-irradiated C1 included in the fit. This was due 
to low inhibition for C1, even at the highest screened concentrations. It is clear, 
however, that irradiation results in increased inhibitory potency at higher 
concentrations. Again, the original compound I2 shows a significantly lower ܫܥହ଴ 
compared to the irradiated C1 (dashed vs. solid line in Figure 37b), due to incomplete 
decaging. 
5.3.5 Inhibiting RET in Live Zebrafish 
The last part in the investigation of photcontrolled RET inhibition was to evaluate the 
effect in a live organism. The zebrafish (Danio rerio) is a popular model organism for 
studying developmental biology, due to its rapid early development, transparency to 
light, and mapped genome. The RET gene is strongly expressed in primary 
motoneurons of humans182  as well as zebrafish183, which indicates a role in their 
development. We therefore reasoned that inhibition of RET during embryonic growth 
could result in phenotypes associated to the motoneurons of the zebrafish. To illustrate 
this, a transgenic tg(olig2:dsRed)184 zebrafish line was used, which labels ventral spinal 
cord precursor cells (that in turn produces motoneurons and oligodendrocytes) with a 
fluorescent protein.185 This allowed for assessment of the morphologies of these 
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neuronal structures by means of confocal microscopy. Because of the extensive 
incubation time in the zebrafish assay (ca. two days, 28.5 ºC), and the rate of the thermal 
Z-I3 → E-I3 isomerization (time constant = 9.7 h at 37 ºC), we opted not to include 
the photoswitch in this part of the study. Instead, we focused on the inhibitory 
capabilities of C1 in the absence and presence of decaging stimulus. The zebrafish 
incubation protocol was as follows; 
i. Compound C1 (50 μM) was added to the zebrafish embryo 
solution 3 hours post fertilization (hpf) in three identical 
preparations, followed by incubation at 28.5 ºC.  
ii. To ensure efficient uptake of the cage, the embryos were 
washed with fresh medium before irradiation (15 min, 
365 nm). One preparation was irradiated at 14 hpf, one at 
24 hpf, while the third was kept in the dark.  
iii. The embryos were left to develop until 48 hpf, whereafter 
their spinal cords were scanned with confocal imaging. ‡‡‡‡‡‡ 
  
Figure 38. In vivo RET inhibition studies on live zebrafish treated with C1. The left panel (a-d) 
shows confocal image stacks of motoneurons in live tg(olig2:dsRed) zebrafish, with triangles 
indicating stalled (white) and erroneous (yellow) axons. Scale bar = 20 μM. e) Quantification of 
axonal phenotypes in the different incubations and controls; n = number of axonal processes 
quantified. 
The results from the zebrafish incubations (Figure 38) show that embryos incubated 
with C1 and irradiated at 14 hpf, display shortened and malformed axons, while the 
corresponding non-irradiated C1 sample had no detrimental effect on the motoneuron 
axonal development.§§§§§§ Interestingly, the timing of the decaging event seems to be 
important, as 24 hpf decaging induced similar, but less severe and significantly fewer 
                                                          
‡‡‡‡‡‡ A control experiment with irradiated, untreated zebrafish (only compound solvent added) was 
also performed, as well as an incubation (including the irradiation step) at a lower C1 concentration (10 μM), 
see Figure 38e.  
§§§§§§  The observed phenotypes could also be induced using the native inhibitor I2 at 10 μM 
concentration (not shown). 
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abnormalities. Importantly, apart from the observed phenotypes, the zebrafish 
embryos exposed to the inhibitor appeared to develop normally, indicating specificity 
toward the RET kinase. In terms of C1 performance, these results show that the 
compound can be taken up and maintained in the zebrafish, and photonically activated 
inside the live organism.  
5.3.6 Discussion and Conclusions 
Two conceptually divergent methodologies have successful been implemented to 
convert knowledge on established drug-target interactions into photocontrolled 
applications. Here, the specific binding interactions of non-photoactive RET kinase 
inhibitors have inspired the design of a photoswitchable and caged inhibitor, shown to 
be effective in three biological assays. Several differences between the two approaches 
can be identified from the presented results and will be discussed below.  
Regarding the change in inhibitor potency upon exposure to light, it is shown that 
the RET activity was reduced by a factor of 12 using the cage, C1. This effect is higher 
even than the theoretical maximum effect (factor of 7.7 given the observed PSD) of 
the photoswitch, I3. This illustrates the significance of the PSD and how it can limit 
the use of photoswitches. For I3, the difference between the observed and theoretical 
maximum switching factor (3.9 vs. 7.7 in the kinasse assay) could be explained by a 
combination of thermal Z → E isomerization (dark reactivation of the inhibitor), and 
non-zero inhibition of the Z-form. The latter explaination highlights another difference 
between the two strategies; infering zero activity by attaching a caging group is arguably 
easier due to the size of the introduced photolabile substituent. The comparatively 
small changes in azobenzene stericity upon photoisomerization, may make the 
photoswitch approach more challenging in this respect.  
Another noteworthy point relates to the rates of the photoreactions. The slow C1 
decaging rate neccesitated an extended irradiation time for C1 compared to I3 (15 min 
vs. 3 min, respectively). Longer irradiation time or higher light-flux (although deemed 
impractical in the applied assays) would increase the observed effect of C1 as complete 
decaging was not triggered by the applied light-dose. For the photoswitch, the rates of 
the photoreaction was not an issue, as photoequilibrium was established much faster. 
In general, rapid activation of effectors can be crucial depending on the intended 
application, and it is clear that the photoswitch is better suited in terms of photokinetics 
under the herein applied conditions. On the other hand, the insufficient thermal 
stability of Z-I3 toward isomerization disqualified I3 from the zebrafish assay. This 
was in sharp contrast to C1, for which no such processes required consideration.  
Another fundamental difference related to the design of the compounds is that 
decaging of C1 yields the very same molecule as the original inhibitor, i.e. I2. However, 
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the inhibitor potency of the active form I3 (E-I3, which was designed to mimic I2) 
displays a 2.1-fold lower inhibitor potency compared to I2 in the kinase assay. This 
shows that the ability to photoswitch came with a cost in potency. Finally, the overall 
utility of developing photocontrolled inhibitors is nicely demonstrated in the zebrafish 
assay, as the time of inhibitor activation (14 hpf vs. 24 hpf) makes a dramatic difference 
in the incidence of neuronal phenotypes. Given the potential issues of uptake kinetics 
and biodistribution within the organism, this degree of  temporal control is likely 
difficult to achieve with conventional drugs.  
  
71 
 
6 Concluding Remarks and Outlook 
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In this thesis I have shown how detailed knowledge on specific binding interactions 
can be converted into photocontrolled applications. I have used the well-known 
molecular transformations inherent to photoswitches and caged compounds to realize 
novel photocontrolled tools for biological use. The presented research was partly 
performed on a basic level, focusing in detail on host-guest binding interactions and 
the general behavior of isolated molecules in solution. From these exclusively 
spectroscopic studies (Papers II, III, and IV), concepts with distinct proof-of-principle 
character were developed and explored. The most important conclusions from these 
efforts are bulleted below. 
x The spiropyran-CB7 system developed in Paper II did not function as 
a photocontrolled drug release scaffold due to loss of bistability. The 
CB7 binding bestowed the spiropyran with ultrastability toward 
hydrolysis. 
x The thermal interconversions of a spiropyran in water can be 
described by an explicit set of rate- and protonation constants, 
according to the kinetic scheme proposed in Paper III. 
x The capture and release of the neurotransmitter 4-aminopyridine can 
be photoreversibly controlled using the P2-DTE system developed in 
Paper IV. The release event can be confirmed by fluorescent means.  
I expect the increasing development of spiropyrans for aqueous and cellular use to 
guarantee some interest in the above findings; in particular the kinetic scheme, which 
allows for exact predictions of the time- and -dependent concentration profile of 
the various forms of the photoswitch. Considering the beneficial effects previously 
reported for CB7-binding (solubilization, enhancement of cell uptake etc., discussed in 
section 5.1.3), the anchor-derived binding approach may be a viable method also for 
other types of photoswitches. The complexation-induced changes in thermal behavior 
of the spiropyran (and possibly other properties of other photoswitches) may also be 
molded into useful applications. However, it is difficult to predict with confidence how 
these findings will be used in future research. 
In proof-of-principle studies, applicability is outweighed by novelty. The release-
and-report scaffold presented in Paper IV serves as a good example. Although not 
immediately applicable to a biological setting, it signifies a noteworthy addition to 
existing intelligent drug delivery systems. The room for improvements is however 
willingly acknowledged. As discussed in section 5.1.5, making the scaffold water 
compatible would be a crucial step. Equally important is to improve the drug release 
ratio. Some structural improvements of the DTE switch could be made to possibly 
enhance the difference in P2 binding strength between the isomers, to drive a more 
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substantial release. The scaffold is however innately limited by the fact that also the 
weakly binding closed isomer (DTEc) competes with the drug for binding sites on P2. 
The latter parts of the results (referred to as parts two and three in chapter 5) focus 
on photocontrolled small-molecules in living systems. In contrast to the former studies 
this can be considered to be closer to an actual biological application. The following 
conclusions are drawn.  
x An apoptotic-like cytotoxic response can selectively be triggered by 
photoisomerizing a DNA-binding spiropyran derivative in live 
human cancer cells (Paper I). 
x Light-controlled inhibition of the RET kinase can be achieved using 
an azobenzene-derived photoswitch (Paper V), or o-nitrobenzyl-type 
caged compound (Paper VI). 
The live cell spiropyran study exemplifies how a biological effect (here: cytotoxicity) 
can be photocontrolled with spatial discrimination, since only irradiated cells 
committed to the death-program. Possible follow-up studies to this work include co-
localization imaging experiment (using emissive probes e.g. for mitochondria) to 
identify preferred intracellular targets of the spiropyran. Further evidence regarding the 
type of death-program being triggered could likely also be gained using e.g. caspase-
based apoptosis probes.186 
The binding site-inspired scheme for developing the photocontrolled inhibitors 
presented in Papers V and VI demonstrates how established methodologies (both 
caging and incorporation of azo-groups into effectors are well-explored procedures) 
can readily be applied to novel targets. The caged compound C1 is currently being 
considered for further studies in zebrafish. 
As for an eventual transition of photocontrolled tools into clinical practice, it 
should be stressed that the current state of the field likely has some way to go. A 
reasonable speculation is that such development would (at least to begin with) be 
dominated by caged applications, as they are less sensitive to complications such as 
dark processes and incomplete conversion. Conceivable targets would likely include 
skin malignancies, due to their accessibility. On the other hand, I believe there is more 
immediate potential for using both caged compounds and photoswitches as biological 
probes to resolve spatial and temporal dynamics of e.g. cell signaling, and would 
welcome further development of these types of experimental protocols. 
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